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ABSTRACT
IMPROVING RESEARCH PARTICIPANTS’ UNDERSTANDING
OF INFORMED CONSENT
by
Debra J. Gillespie

The University of Wisconsin-Milwaukee, 2017
Under the Supervision of Professor Rachel Schiffman
Twenty-five to sixty percent of research participants are unable to understand important
information during the research consenting process. This lack of comprehension may
unintentionally expose research participants to potential harm. The purpose of this study was to
test the teach back method of communication as an intervention to improve research participants’
understanding of informed consent. The Shannon Weaver Communication model was the
theoretical framework supporting this study. The pre-intervention sample (control group) of 18
participants enrolled in a cardiology clinical trial at a large tertiary hospital in New England
completed the Quality of Informed Consent (QuIC) survey. Two cardiology research
coordinators were trained in teach back communication as the intervention. A post-intervention
sample (experimental group) of 5 participants completed the QuIC survey.
There was no significant difference in mean scores of objective understanding between
the pre-intervention and post intervention groups. There was also no significant difference in the
relationship between objective and subjective understanding in the pre-intervention group
compared to the post intervention group. There was poor understanding of compensation for
research-related injury where 50% of the pre-intervention group and 60% of the post intervention
group were either unsure or answered questions related to this concept incorrectly.
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Another poorly understood concept was with a description of the procedures to be
followed. Sixty-one percent in the pre-intervention and no one in the post intervention group
understood this concept. A Chi-square test for independence indicated no significant association
between highest educational level obtained and understanding of compensation for researchrelated injury or an understanding of procedures to follow.
With the uncovering of a poor understanding of the two concepts of compensation for
research-related injury and procedures to follow, not reported in the literature, more research
specifically targeting these concepts and participants’ understanding are warranted. Inductive
and deductive approaches may yield interesting results. Institutional and national policies need to
be put into place assuring participant understanding of all regulatory requirements. However, the
practical application of such policies cannot be mandated until there is comprehensive science
available to support its practice.
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CHAPTER 1 STATEMENT OF PROBLEM
According to the Institute of Medicine (IOM) more than 177,000 registered research
studies involving human participants are currently taking place in 187 countries representing a
small portion of ongoing clinical research worldwide (IOM, 2013). With every clinical trial there
are inherent risks about which every individual needs to be informed before making a decision as
to whether or not to participate. There is a body of knowledge demonstrating that research
participants have significant misunderstandings about the potential benefits, risks and other
aspects of their research study (Barrett, 2005; Bergenmar, Molin, Wilking, & Brandberg, 2008;
Flory & Emanuel, 2004; Hietanen, Aro, Holli, Schreck, Peura, & Joensuu, 2007; Jefford et al.,
2010; Joffe, Cook, Cleary, Clark, & Weeks, 2001; Meade, 1999; Palmer & Trott, 2013; Paris et
al., 2007; Schwartz & Appelbaum, 2008). As many as 25-60% of research participants are
inadequately informed and/or are unable to recall or understand important information during the
research consenting process (Aaronson, et al., 1996; McCarthy, Waite, Curtis, Engel, Baker &
Wolf, 2012). If research participants agree to enroll into a research study without truly
understanding all aspects of the study they might unintentionally be exposed to potential harm
The purpose of this study was to empirically test the teach back method of communication in
research participants as a method to improve objective understanding of informed consent.
Informed Consent for Research
Obtaining informed consent for research is not just the signing of a document, but rather
a process of developing a relationship between the investigator or member of the research team
and the potential research participant, in order to provide the participant with the full and
complete information needed to make a voluntary informed decision including time to have
questions about the research study answered. Research studies may expose participants to risks
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or burdens they would not normally face. It is therefore imperative that potential research
participants be knowledgeable about these risks and burdens through the informed consent
process (Wendler & Grady, 2008). Clear communication and an assessment of participant
understanding are a critical part of the relationship between the investigator and the potential
research participant. Informed consent can be said to have been given by a participant once the
participant has acknowledged they have a clear appreciation and understanding of the facts,
implications, and future consequences of an action.
Background
In 1932 the United States Public Health Service began a research study to investigate the
clinical course and progression of syphilis. Black, African American men living in Alabama
were recruited to participate by the offer of free medical care. The majority of the men recruited
by the investigators were sons and grandsons of slaves, impoverished and had never seen a
doctor or received medical care. Thus, the men showed up in hordes. While being screened for
the study’s inclusion criteria of having venereal disease, the research physicians never disclosed
to the participants they had syphilis. As physicians studied the natural progression of syphilis, for
further enticements, families were offered fifty dollars towards burial insurance. With the new
discovery of penicillin as a powerful treatment for syphilis, the treatment was withheld to the
research subjects in order for the physicians to monitor the diseases progression. The researchers
justified the lack of treatment by explaining that these men would not normally be receiving
medical care, so why miss the opportunity to study the natural progression of the disease. The
study was originally designed to last 6 months, but continued to enroll and monitor syphilis
stricken men for forty years. The study came to an abrupt halt in 1972 when it became public
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knowledge after one of the former venereal disease investigators disclosed to a reporter the
unethical conduct of the study (Thomas, 2000).
An institution on Staten Island, New York, named Willowbrook served the mentally
retarded population from 1947-1987. A research study, partly funded by the United States
Armed Forces, Department of Epidemiology, was undertaken in 1955 to study the progression of
and treatment of hepatitis. Children living at Willowbrook were purposely fed fecal matter
extract and given doses of the live hepatitis virus. Although parental consent was obtained, the
investigators did not disclose to parents the risks of participation (Robinson & Unruh, 2008).
Investigators had discovered high rates of hepatitis among the residents at Willowbrook and
hypothesized that if children were deliberately given an injection of live hepatitis viral strain,
they would develop immunity. The hepatitis experiments at Willowbrook are commonly cited as
one of the most serious ethical breaches since the Nazi human experimentations of World War II
(Robinson & Unruh, 2008).
In response to the travesties of the Nazi human experimentations during World War II,
and the unethical conduct of research involving human subjects from the Tuskegee Study, and
the Hepatitis study at Willowbrook, the National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research published a landmark report, “Ethical
Principles and Guidelines for the Protection of Human Subjects for Research” commonly
referred to as the Belmont Report (National Commission for Protection of Human Subjects of
Biomedical and Behavioral Research, 1979). Contained within the Belmont Report are three
ethical principles guiding research conduct with human participants. These principles include
respect for persons, beneficence and justice. The focus of this paper is the principle of respect for
persons, which honors individuals’ right to choice and emphasizes potential research participants
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must have the capacity to consent as well as comprehend any risks and benefits (Shuster, 1997).
Working within this principle, investigators are required to provide a consent process to potential
research participants with sufficient knowledge and understanding of research for informed
decision making (Whitney, 2001).
It is common for research consent forms to contain structured and technical language to
disclose participants’ rights and responsibilities (Institute of Medicine, 2004). The practice has
been that informed consent documents are typically written at the same reading level as papers
written for medical journals (Green, Duncan, Barnes, & Oberklaid, 2003). In addition, the
informed consent process is often seen as “bureaucratic form filling” rather than an important
and necessary part of the research process requiring time, insight and communication skills
(Banner & Zimmer, 2012). Institutional Review Boards (IRB) often provide investigators with
templates for writing informed consent documents that satisfy the IRB’s requirements but do not
take into account the specific verbiage needed for the study’s population.
For research participants to give informed consent, four conditions must be met:
disclosure, comprehension, capacity to understand and voluntary nature (Iltis, 2006). For
complete disclosure investigators must provide potential participants with sufficient information
regarding the nature and purpose of the study, the risks and benefits, alternatives, costs and
protection of confidentiality. Comprehension refers to the language used in the informed consent
document and must be at a level potential research participants can understand. Capacity to
understand refers to research participants being legally competent and able to appreciate the
information given to them and finally, participation in research must be voluntary in nature with
the option of declining to participate while not jeopardizing their clinical care or right to other
resources (Iltis, 2006).
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The essential elements of informed consent are defined in the United States Department
of Health and Human Service’s Code of Federal Regulations (CFR) and include: the purpose of
the research, risks and benefits of participation, voluntary nature of participation, a distinction
between research and clinical care, potential for compensation for a research-related injury, the
opportunity to ask questions and alternatives to participation (Office of Human Research
Protection, 2009). The CFR’s has recently been revised and several sections on informed consent
have been updated specifically in regards to “new requirements relating to the content,
organization and presentation of information included in the consent form to facilitate a
prospective subject’s decision about whether to participate in research…” (Federal Register,
2017, p. 7210). The impetus for these changes came from arguments stating that consent forms
have evolved over time to be documents more designed to protect institutions from liability
rather than provide individuals with decision-making information, along with the growing length
and complexity of these forms making reading and comprehension difficult (Beardsley, Jefford,
& Mileshkin, 2007; Federal Register, 2017). These new regulations take effect January 2018 so
it remains to be seen what if any effect there will be to participants’ understanding as a result.
Obtaining informed consent for research is essential for ethical conduct and a
requirement of these federal regulations (Flory & Emanuel, 2004). To make the consent process
truly informed, participants must be given sufficient, understandable information to allow
independent decision making (Lansimies-Antikainen, Pietila, Laitinen, Schwab, Rauramaa, &
Lansimies, 2007). This honors individuals’ autonomy and protects them from potential harm
(Antoniou, Draper, Reed, Burls, Southwood, & Zeegers, 2011). Research participants’ signing of
a consent form serves as documentation of their consent and voluntary participation and satisfies
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legal and ethical requirements (Armstrong, Dixon-Woods, Thomas, Rush, & Tarrant, 2012;
Banner & Zimmer, 2012).
In 2007 the Food and Drug Administration (FDA) Amendment Act mandated the
registration of human subjects’ research involving drugs and/or medical devices approved for use
in the United States (Califf, Filerman, Murray, & Rosenblatt, 2012). The National Institute of
Health (NIH) developed the database (clincialtrials.gov) for the registration. Each week more
than 330 research studies are registered on the database, which is the repository for more than
177,000 studies (Califf et al., 2012). The Clinical Trials Cooperative Group, which is sponsored
by the National Cancer Institute (NCI) registers more than 25,000 research participants every
year from more than 3,100 organizations which include more than 14,000 research investigators
in the United States, Canada, and Europe (National Cancer Institute, 2009). Given the large
volume of research studies currently being conducted, and the plethora of research demonstrating
participants’ lack of understanding of informed consent for research, it is imperative that
interventions to address the issue of respect for persons, including improving comprehension of
informed consent be addressed.
Problem Statement
Clear communication is an important element of healthcare quality and patient safety
(Institute of Medicine, 2001), yet 47% of Americans, roughly, 90 million, have difficulties
understanding health information given to them by their providers (Wilson, 2009). It has been
documented that patients absorb and recall only about half of what physicians have
communicated to them (Schillinger et al., 2003). In addition, approximately 40-80% of medical
information is forgotten almost immediately with the greater the amount of information being
given proportional to the amount of information forgotten (Kessels, 2003). Adding to these
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alarming statistics is the difficult readability of informed consent documents, particularly
documents for research participation. Readability is described as the person’s ability to read and
understand written material (Redish & Selzer, 1985). A document’s readability is determined by
a mathematical formula applied to written texts in order to predict how difficult the material will
be for any group to read and understand. This is determined by counting the number of syllables
per word and number of words per sentence (Buccini, Iverson, Caputi, & Jones, 2010).
Readability scores are expressed as a grade level equivalent to the number of years of formal
Western education. Nearly half of American adults read at or below an 8th grade reading level
(National Center for Education Statistics, 2003). However, most informed consent documents are
written at a 10th grade reading level or higher (Pfizer, 2014). Written materials for research
participants must explain complex ideas and information, including the purpose of the study, in
depth study procedures, and confusing privacy laws.
Buccini et al. (2010) evaluated the readability of research consents for Human
Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) and Type 2
Diabetes research. Ten consent forms from each group were assessed for readability using the
Simple Measure of Gobbledygook (SMOG) and Gunning Fog Index (FOG). Both the SMOG
and the FOG are calculated from a free online readability calculator which records readability
from grade 4 up to grade 18 (post graduate education). Readability scores for both groups of
documents ranged from a grade level of 9.4 to 16.6. The mean reading grade level for the
HIV/AIDS consent document was 14.0 and the mean level for the Type 2 Diabetes document
was 13.3. The authors recognize this does not meet the local ethics committee’s
recommendations for an 8th grade reading level for research consent documents.
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Hopper, TenHave, and Hartzel (1995) also assessed consent documents used for
radiology research. The authors evaluated 284 consent forms from 156 different institutions. The
sample was taken from active members of the Association of University Radiologists. The
authors used a computerized software program, Right Writer 4.0, to analyze readability based on
the year of education, with a readability index of less than 6 considered simple, a readability of
6-10 considered a good document and more than 10 indicating a complex document. The mean
readability score for the consent forms was 12 with a range of 8-17. The authors recognized that
the readability of research consent forms used in radiology were too complex for the average
person to comprehend. Sharp (2004) and Ogloff and Otto (1991) found similar results when
assessing consent documents for psychology and oncology research. These studies are also
supported by LoVerda, Prochazka, and Byyny (1989) who evaluated research consent documents
used at the Veterans Administration Medical Center, where the authors found that the average
reading level was 13. 4 and 22% of all text passages were at the post-graduate level. Grossman,
Piantadosi, and Covahey (1994) and Cheung, Pond, Heslegrave, Enright, Potanina, & Siu (2010)
found similar results with oncology research consent forms. Beardsley et al., (2007) show that in
recent years, the average number of pages in oncology research consent forms has increased
from 7 to 11. In addition, in oncology research, very long (20 letter) words are expected to be
read and understood by participants who may have recently received a devastating diagnosis, and
are in a fragile state of mind contributing to the difficulties of their understanding (Griffith,
Wright, Hackworth, & Gilheart, 2012). Terminally ill patients may be eager to enroll into a
research study believing it their last chance for a “cure” and thus negate the potential for risks.
Of particular consideration to investigators is the fact that people with chronic mental and/or
physical health conditions are among several vulnerable populations whose reading level is
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below the 8th grade national average (Plain Language and Action Information Network, 2014).
Given what is currently known about the length and complexity of the language used in research
consent forms, it is important for investigators to assign enough time to adequately discuss all the
elements within the consent form and to assess potential research participants’ understanding
during the consenting process. Kemp, Floyd, McCord-Duncan, & Lang (2008) believe that
asking simple yes/no questions is not adequate to assess understanding. The authors’ state there
may be times when patients did not understand instructions well enough to formulate a question
and therefore simply respond “no” when asked if they have any questions (Kemp et al., 2008).
Despite the plethora of research on patients’ misunderstanding of medical information,
physicians still do not routinely check for understanding during clinical encounters with patients
(Kemp et al., 2008). The potential for harm may increase significantly when enrolling into a
research study without fully understanding the risks.
Despite 25 years of research describing the problem with informed consent processes,
empirical evidence testing interventions to improve communication and participant
understanding during the informed consent process have primarily been conducted with
Oncology patients. This may be due to the potential high risk to participants when testing new
cancer treating pharmaceuticals as well as initiatives from the National Cancer Institute (NCI)
for improving informed consent for research participants (National Cancer Institute, 2009). Other
studies have tested interventions at improving informed consent understanding among HIV
patients, healthy volunteers or asthmatic patients (Coletti, Heagerty, Sheon, Gross, Koblin,
Metzger, & Seage, 2003; Dresden & Levitt, 2001; Paris et al., 2007; Sengupta, Lo, Strauss, Eron,
& Gifford, 2011; Stunkel et al., 2010). Only a few studies were found that enrolled Cardiology
patients (Bjorn, Rossel & Holm, 1999; Kripalani, Bengtzen, Henderson & Jacobson, 2008). All
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of these studies have mixed results or lack a theoretical framework. Given the potential risks
involved in research participation, it is imperative that interventions to improve the research
consenting process be empirically tested, thereby enhancing communication, participant
understanding and ensuring true voluntary participation.
With increasingly complex and sophisticated research protocols, high-risk treatment
options, an aging population at risk of cognitive impairment and an increased awareness of the
overwhelming problem of low health literacy, there is an urgent need to ensure that participants
truly understand all aspects of their research study prior to consenting. To make sure that
research participants are truly informed, information must be communicated in a manner they
can understand (Lansimies-Antikainen et al., 2007). One place to start would be to look toward
communication theories as a possible framework to guide studies specifically testing
interventions to improve research participants’ understanding of informed consent.
The overarching concept of this dissertation is communication as it pertains to informed
consent for research. Although the current state of the science informs us of participants’
misunderstandings of the research study in which they participate, and poor health literacy in this
country, empirical studies testing specific interventions that influence the degree to which
participants understand or misunderstand research participation information have limitations.
Many of the interventions that have been empirically tested have focused on simplifying
the language in the informed consent document or providing potential research participants with
other consenting methods such as the use of videos. When conducting an extensive literature
search on this topic, only one study was found that tested the teach back method of
communication in this cohort (Kripalani et al., 2008). No studies were guided by a theoretical
framework. Additionally, the majority of studies testing interventions to improve research
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participants’ understanding have been conducted with Oncology patients. No studies were found
that addressed interventions improving understanding for patients enrolled in cardiology clinical
trials. Therefore, this study will address these gaps in the literature and add to the body of
science for this potentially vulnerable population.
Theoretical Framework
Communication is a complex behavior, combining physical and mental events, with the
aim of exchanging messages between two or more individuals (Schindler, Ruoppolo, & Barillari,
2010). The field of communication is very broad and encompasses many forms of
communication from interpersonal communication to public broadcasting to the masses, to
speech and language development. Communication theory may be used to understand, explain
and predict health beliefs, attitudes, intentions, and behaviors of individuals, dyads, or groups
(Bylund, Peterson, & Cameron, 2012). “An interesting and novel focus for improving consent
could be creating interventions designed explicitly on improving communication skills”
(Nishimura, Carey, Erwin, Tilburt, Murad, & McCormick, 2013, p. 12). The following section
will describe the communication model used to support this research.
Shannon Weaver Model of Communication
The Shannon Weaver model of communication (Figure 1) was first developed in 1948
by engineers from Bell Laboratories who felt the need to develop a framework around signal
transmissions with telephone line capacities and distortions. Weaver then extended the
framework to other kinds of communication and developed the philosophical aspects of the
framework as it applies to communication in general (Shannon & Weaver, 1948). The Shannon
Weaver model contains the following elements required for communication: information source
(sender), transmitter (encoder), channel, reception (decoder), and the destination (receiver). The

11

sender is the person who starts the conversation with a message he/she wishes to convey. The
sender encodes the concept of what he/she wants to communicate by putting it into an
understandable format for the receiver to be able to interpret. Decoding occurs by the receiver as
he/she interprets the message. The message is the idea or concept with a distinct meaning. The
channel is the route the message is sent and can be verbal or written, on paper, or electronic. The
authors further explain that the communication or message is effected by noise that may occur
within the channel. Level A noise is referred to as any interference or distortion that may lead to
changes in the initial message such as the static one hears on the telephone line or the physical
noise in the room. Level B noise is the semantic noise such as the vocabulary the source has
chosen to use that may potentially contribute to misunderstanding of the message. The
vocabulary used by the sender is problematic when it contains medical terminology that the
receiver may not understand. This “noise” leads to misunderstanding of the message. Shannon
and Weaver (1948) state that in order for communication to be clear, the noise must be reduced.
The next step in the model is the feedback loop. This is where the sender asks the receiver to
state back in their own words what they heard as the message. If the message is inaccurate the
sender has the opportunity to provide clarification of any miscommunication and an opportunity
for the sender and receiver to ask questions as necessary.
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Figure 1. Shannon-Weaver Communication Model
The Shannon Weaver Model of Communication was applied to empirically test the
communication intervention of “teach back” to determine whether or not this communication
method improved research participants’ understanding of the informed consent process,
including specific required elements of informed consent as required by federal regulations
(Figure 2). It was hypothesized that the teach back method of communication would improve
research participants’ understanding of informed consent in the following ways: provide new
skills to the sender (research coordinator) to encode complex medical and scientific concepts into
lay language which would decrease the noise by avoiding the over use of medical terminology,
along a verbal channel during the initial informed consent process. The feedback loop (teach
back) is where the receiver (potential research participant) states back in his/her own words what
it is he/she heard/understood the sender to say. By applying the principles of teach back it was
hypothesized that there would be a reduction of Level B noise thereby leading to an
improvement of the receiver’s (potential research participant) interpretation and understanding of
the complex information provided at the time of obtaining informed consent for research.
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Research
Investigator or
research
coordinator

Investigator or
coordinator encodes
medical and scientific
concepts into lay
language

Verbal explanation
of research study in
lay language during
consenting process

Potential research
participant decodes
message to interpret
meaning

Hypothesis:
decreased
noise

Potential research participant “teaches back”
risks and other aspects of the study for
clarification and confirmation

Figure 2. Modified Shannon Weaver Model as Applied to Research Consenting

Interpersonal communication is a key component of the research investigator and
potential research participant relationship. The teach back method of communication has been
described as when the patient is asked to state back in their own words, to the educator, what
they have learned (Negarandeh, Mahmoodi, Noktehdan, Heshmat, & Shakibazadeh, 2012).
Teach back was developed to allow the educator to determine if the communicated message was
received correctly, thus allowing for the message to be tailored to each individual’s literacy level.
This relatively simple and quick method allows the educator to evaluate the patient’s level of
understanding. Teach-back has demonstrated increased patient comprehension leading to
improvements in clinical outcomes (Kornburger, Gibson, Sandowski, Maletta, & Klingbeil,
2013; Negarandeha, et al., 2012). Yet this simple communication strategy has not been widely
tested as a method of communication when obtaining informed consent for research
participation.
In a study by Kemp et al., (2008) patients viewed three physician-patient scenarios of
teaching: a yes/no conversation, a Tell-back Directive method and a Tell-back Collaborative
14

(teach back) method for inquiring about patient understanding of new medical information. The
yes/no method was used as it is frequently applied in practice and allows for only closed-ended
responses when patients are asked if they understand their instructions. The Tell-back Directive
used an authoritative, paternalistic approach to assessing patient understanding and the Tell-back
Collaborative approach asked patients to tell back in their own words what the physician had
said in order for the physician to assess his/her own communication. This method creates an
environment where patients do not need to feel embarrassed if they do not understand their
instructions and is the recommended approach (Weiss, 2003). The Tell-back Collaborative
method was preferred by patients when compared to the Tell-back Directive and the yes/no
method (Kemp et al., 2008).
Nishimura et al. (2013) conducted a meta-analysis of randomized clinical trials testing
interventions to improve participant understanding of informed consent for research. The metaanalysis was conducted on 22 interventions which included the use of multi-media, enhancing
the informed consent document and extended discussion. There were no significant increase in
participants’ understanding with the use of multi-media, but there were significant increases in
understanding among research participants when alterations were made to the informed consent
document (shorter and lower reading level) and having an extended discussion. The authors
concluded that when using extended discussion approaches there was an increase in participants’
understanding when compared with a controlled consent discussion and state there is no
substitute for personal communication where there is the opportunity for questions and answers
(Nishimura et al., 2013). Dunn and Jeste (2001) had similar conclusions from their systematic
review of participants’ understanding of informed consent for research and state one effective
intervention is that of corrected feedback. “Learning to develop communication skills to obtain
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feedback and verify successful communication is critical to working competently with others,
and contributes to addressing the problem of health literacy” (Institute of Medicine, 2004,
p.118). These systematic reviews as well as the IOM’s report suggest the teach back process of
communication may be one possible intervention to improve research participants’
understanding. Given the plethora of research demonstrating research participants’
misconceptions during and after the informed consent process, more studies examining the
communication between the investigator and the potential research participant are needed.
Purpose
The purpose of the current study was to empirically test the teach back process of
communication when obtaining informed consent for research participation.
Research Questions and Hypotheses
The research questions for this study were expressed using the Patient, Intervention,
Comparison, and Outcome (PICO) method (Stillwell, Fineout-Overholt, Melnyk, & Williamson,
2010). The research questions driving this study were 1. In research participants, will the use of
the teach back process of communication compared to standard language, improve objective
understanding of informed consent? 2. In research participants, is the relationship between
objective and subjective understanding different in the control group (standard communication)
compared to the experimental group (teach back communication)?
The following hypotheses were proposed for testing in this study: participants will have a
greater understanding of the risks, benefits and other key elements of their research study after
receiving the teach back process of communication. A secondary hypothesis is that there will be
less of a difference between objective and subjective understanding within the experimental
group.
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Independent and Dependent Variables
The independent variable was the teach back process of communication (the
intervention) and the dependent variables were participants’ objective and subjective
understanding as measured by scores on the Quality of Informed Consent (QuIC) Instrument
developed by Joffe, Cook, Cleary, Clark and Weeks (2001).
Significance to Nursing
According to Carper (1978) a profession will determine the kind of knowledge it aims to
develop by organized, tested and applied means. Carper (1978) challenges the nursing profession
to develop an empirical body of knowledge specific to nursing yet this scientific quest has been
slow. Knowledge and the scientific foundation of any profession is developed using strict
methodological rigor involving the conduct of human subjects’ research. Traditionally, clinical
nurses have had very little involvement in nursing research. While an introductory course in
research may be offered at the Baccalaureate educational level, once graduated, those research
concepts have not been applied to practice. Nurses’ involvement with research has evolved over
the past thirty years as the profession has undergone a paradigm shift from technical and task
oriented to a more autonomous, science-based profession (Smirnoff, Ramariz, Kooplimae,
Gibney, & McEvoy, 2007). With this shift has come an expectation that the nursing profession,
including clinical nurses will embark upon scientific inquiry to define its practice.
In recent years the evidence-based practice (EBP) paradigm has gained momentum
within the nursing profession with clinicians and administrators embracing EBP to make practice
changes for improvements in patient outcomes. With the EBP paradigm comes the expectation
that clinical nurses will lead practice changes. This requires the ability to not only be an evidence
consumer, but an evidence creator as well. When there is an area of clinical practice that does
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not have an evidence base, nurses, with appropriate preparation and guidance from doctorally
prepared nurses need to design and conduct research studies. Bedside clinicians conducting
research is a relatively new phenomenon with many nurses not having the specific knowledge
and skill set. Additionally, nurses working in the role of research coordinator have little formal
education and training for that role, yet are often required to obtain informed consent from
potential research participants. Particularly important is the knowledge of regulatory
requirements when obtaining informed consent for research as well as the roles and
responsibilities of the Principal Investigator.
Although there is a plethora of research studies addressing the issue of poor
comprehension among research participants, few studies have been published in nursing
journals, those typically read by nurses. Additionally, many recently published books on the
conduct of nursing research do not address the regulatory requirements and other issues for
obtaining informed consent for research participation.
Although there are many research translation models currently adopted by organizations
none specifically address how to enroll participants into a research study. Informed consent and
the communication skills needed to obtain and assess participant understanding are currently not
a part of the national nursing dialogue.
In 1994 the American Nurses Association (ANA) published a position statement,
Education for Participation in Nursing Research which outlines nurses’ involvement in the
conduct of research from the Associate degree through the Doctoral degree educational level.
Although the Associate Degree prepared nurse may be involved in research by identifying
clinical issues and data collection, it is at the Baccalaureate educational level where the ANA
describes nurses’ involvement with human subject and potential research participation. “Ethical
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principles are a big part of the baccalaureate education, not the least of which is the protection of
human subjects” (American Nurses Association, 1994).
The American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program
requires hospitals to document how clinical nurses are evaluating and incorporating research into
their professional practice. ANCC also expects clinical nurses to take the lead on process
improvement changes and to disseminate results internally and externally (Weierbach, Glick,
Fletcher, Rowlands, & Lyder, 2010).
This paradigm shift in nursing practice will require doctorally prepared nurse scientists
working in the clinical arena to serve as research mentors to clinical nurses. According to
Aaronson et al. (1996) “remarkably little attention has been paid to the potential contribution of
nurses to the informed consent process” (p 985). Given the amount of time nurses spend with
patients, both in the inpatient and outpatient settings, and their role in education, nurses are better
positioned to provide and reinforce information patients have heard during the informed consent
process. In order to be able to assist with this education and clarify any misunderstandings
research participants may have, nurses need the knowledge of the federally mandated consent
required in each research consent document.
Although one may agree clinical nurses’ involvement in evidence-based practice a good
thing, obtaining informed consent from potential research participants takes an additional skill
set not traditionally provided in primary nursing education. Doctorally prepared nurse scientists
have the analytic abilities to design research studies around clinical questions and the knowledge
of regulatory requirements when conducting research. As more and more hospitals are seeking
ANCC’s Magnet recognition, with its research requirements, more and more hospitals are hiring
doctorally prepared nurses to serve as mentors to staff. When these nurse scientists conduct their
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own research studies and/or are mentoring others they must incorporate these best practices
when obtaining informed consent.
Finally, this study will advance the science on what is currently known about teach back,
empirically test the teach back communication process in the understudied cohort of Cardiology
research participants and test the use of the Shannon Weaver Communication Theory.
Breakdown in communication most often occurs during the decoding of the message by the
receiver (Odell, 1996). Schramm (1954) points out that the more commonalities there are
between the sender and the receiver the more likely the chance of the message being interpreted
as intended. One way to enhance the commonalities is to avoid the use of medical terminology
and jargon. Decreasing the use of medical terminology is one of the steps in the teach back
training process.
Chapter Summary
Meade (1999) recognized the absence of underlying theoretical frameworks supporting
empirical research on informed consent and suggests scholars look towards the discipline of
communication. Despite the plethora of research on participants’ understanding of informed
consent, most studies do not propose a specific theory for conducting or improving the informed
consent process (Sankar, 2004). According to Conn, Rantz, Wipke-Tevis, & Maas (2001) an
intervention is more likely to be effective if based on a model or theory and in particular reflect
key constructs within the conceptual framework. Without relating the intervention to a theory or
framework, the results are likely to be misinterpreted. Furthermore, innovative communication
interventions need to be developed and tested to assist informed consent for research (Meade,
1999). This research study will add to the body of the science by incorporating a communication
theoretical framework.
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Structure to Dissertation
This dissertation is organized in the following manner: Chapter 1 provided a brief
overview of the topic. Chapter 2 is divided into Parts A and B and includes two manuscripts. Part
A is a critique of the theoretical framework supporting this dissertation and Part B is a systematic
review of the literature to describe the current state of the science. In Chapter 3 the research
methods including design, sample, research questions, hypotheses, intervention and data analyses
are described. Chapter 4 presents the results of this study and includes the third manuscript. In
Chapter 5 the study is summarized, limitations addressed and a discussion of implications for
nursing, policy and future research are provided.
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CHAPTER 2 REVIEW OF LITERATURE
This chapter consists of two manuscripts. The first manuscript is a critique of the
Shannon Weaver Communication theory. The second manuscript is a systematic review of the
literature.
Teach Back has been published by the Joint Commission as one of its top patient safety
goals (The Joint Commission, 2007). The National Quality Forum also endorses teach back as
part of best practice (Wu, Nishimi, Page-Lopez, & Kizer, 2005). Additionally, teach back is a
requirement for the American Nurses Credentialing Center’s (ANCC) Magnet Recognition
program. This has led to teach back being implemented in many healthcare organizations. With
more and more hospitals implementing teach back and more literature being published on its
empirical use, an article critiquing a communication theory to support teach back is timely. The
Journal Research and Theory for Nursing Practice was chosen as the journal for submission for
this manuscript. This journal was chosen because it is a peer-reviewed journal that primarily
publishes knowledge development in a broad sense to include issues relevant to making
improvements in nursing education and practice. Formatting per the journal’s requirements will
be completed prior to submission.
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Abstract
With the Joint Commission’s revelation that as much as 65-70% of the time
miscommunication has been discovered to be the root cause of many sentinel events, it may be
timely to examine a communication theory to support practice improvement efforts. Effective
communication has been shown to decrease medical errors, improve patient satisfaction, and
increase adherence to treatment plans leading to better health outcomes yet very few studies have
examined communication theories and their applicability to practice. This article will examine
the Shannon Weaver Communication Theory as one theory that may support future studies
examining the teach back communication method as a means to improving patient health literacy
leading to improvements in clinical practice.
Keywords theory, communication, teach back
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Introduction
A theory is a coherent and non-contradictory set of statements, concepts or ideas that
organizes, predicts and explains phenomena, events, and behavior (Bem & Looren-de-Jong,
1997). Theories are common in the social sciences such as psychology, sociology and nursing to
develop an understanding of basic and clinical sciences. “Theoretical thinking in nursing uses
concepts and their relationships to organize and critique existing knowledge and guide new
discoveries to advance practice” (Higgins & Moore, 2000 p. 179). A formal method for
theoretical analysis is important in order to determine if the theory has the potential to be useful
in the educational, clinical or research arena. By analyzing a theory, the theory’s attributes
maybe optimized to guide clinical practice. The following six steps of theory analysis as outlined
by Walker & Avant (2010) were employed as the Shannon Weaver Communication theory
(Figure 1.) was critiqued: 1. identify the origins of the theory 2. examine the meaning of the
theory 3. analyze the logical adequacy of the theory 4. determine the usefulness of the theory 5,
define the degree of generalizability and the parsimony of the theory and 6. determine the
testability of the theory(Walker & Avant, 2010).
The Origins of the Shannon Weaver Communication Theory
In 1947, Shannon, a research mathematician at Bell Laboratories developed a
communication theory to explain data transmitted over telephone lines. The purpose of the
theory was to describe signal transmissions with maximum capacity and minimal distortions
(Shannon & Weaver, 1948). This theory describes technical problems with the accuracy of both
the signal and the speech being transferred from sender to receiver. The Shannon Weaver model
was based on information theory to describe the predictability of messages being received
accurately. Although the theory first described telephone signal transmissions, the original linear
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model was later adapted to describe the flow of information with a feedback loop from the
receiver to the sender added to the model to better describe inter-personal communication
(Shannon & Weaver, 1948). The authors recognize that certain characteristics distort, or change
the way a message was intended. For example, static on the telephone line or medical
terminology used by healthcare professionals to lay persons may contribute to the message being
misinterpreted by the receiver.
The Shannon Weaver Communication theory is historically significant as it was
described at the time telephone and computer technologies were being developed post World
War II. Many people working in the field of human communication had difficulties
understanding the formulas used in Shannon’s mathematical theory, but the pictorial model is
easy to understand. The source-channel-receiver diagram quickly became the standard
description of interpersonal communication during conversations between two people. The
terminology used in the model is still the basis for the description of interpersonal dialogue
(Griffin, 1997).
The Meaning of the Theory
According to Walker & Avant, (2010) the meaning of the theory refers to its concepts
and the relationship among them. The Shannon Weaver model contains the following concepts
required for communication: information source (sender), transmitter (encoder), channel,
reception (decoder), and the destination (receiver). The sender is the person who starts the
conversation with a message he/she wishes to convey. The sender encodes the concept of what
he/she wants to communicate by putting it into an understandable format for the receiver. The
channel is the route the message is sent and can be verbal or written, on paper, or electronic.
Decoding occurs by the receiver as he/she interprets the message. The message is the idea or
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concept with a distinct meaning. The authors further explain that the message may be distorted
by noise that occurs within the channel. Level A noise is any interference that may lead to
changes in the initial message such as the static one hears on the telephone line or music playing
in the room. Level B noise is the semantic noise such as the vocabulary the source has chosen to
use that may potentially contribute to misunderstanding of the message. For example, the
vocabulary used by the sender is problematic when it contains medical terminology that the
receiver may not understand. This “noise” leads to misunderstanding of the message. Shannon
and Weaver (1948) state that in order for communication to be clear, both level A and level B
noise need to be reduced. The final step is the feedback loop. It is during the feedback loop that
the sender asks the receiver to state what he/she heard as the message, provide clarification of
any miscommunication and an opportunity for the receiver to ask questions. This feedback loop
takes the model from its original linear conception to reflect what is more consistent of dialogue.
Frandsen and Millis (1993) recognize the feedback loop has been absent in many other
communication theories. Schillinger et al. (2003) describe feedback as the “communication
loop.”
The Logical Adequacy of the Theory
To understand the logical adequacy of a theory the analyst must examine the outcomes
the theory is able to predict. For the Shannon Weaver Communication theory, the concept of
noise predicts whether or not communicated messages are received as intended. When analyzing
the theory we need to ask ourselves if the flow of the relationship among the concepts makes
sense, seems logical and is able to make predictions. When viewing the diagram of the Shannon
Weaver Communication theory, the reader can quickly assess the relationships among the
concepts by the use of the arrows denoting messages from the sender, through a communication
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channel and to the receiver. Likewise, the reader is able to understand by the arrow from the
receiver back to the sender that this part of the theory explains the concept of feedback. This
structure is logical and able to make the predictions of communicated messages received both
accurately and inaccurately, depending upon the level of noise. The model does not predict when
or where noise will occur, but make suggestions for decreasing the level A and level B noise to
improve upon the probability of the sender’s message being accurately received.
The Usefulness of the Theory
A theory is considered useful if researchers are able to use it to explain phenomenon,
offers new insights into a phenomenon, and make predictions based upon the theory (Walker &
Avant, 2010). The theory should identify which clinical issues may support its use, and if the
theory has the potential to influence practice, education or research (Walker & Avant, 2010). If
the theory is new then it should make significant contributions to the field in which it was
developed. The time in history immediately after World War II saw an explosion in information
technology with further development of the telephone and the television. The Shannon Weaver
Communication theory first described at this time, made significant contributions that helped
explain how communication was sent, received and interpreted over telephone lines and was
later adapted to include a description of interpersonal communication. The Shannon Weaver
Communication theory is one of the most widely used inter-personal communication models.
Part of its success is in its ability to explain how communication works, and how communication
fails (Foulger, 2004).The body of research conducted on healthcare communication has primarily
focused on physician patient communication, specifically from the perspective of the physician
giving the patient bad news (Sheldon, Barrett, & Ellington, 2006). For nurses working in a busy
and complex healthcare environment, communication may often become hurried and medically
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oriented yet very few studies have focused on the nurse patient communication (Sheldon et al.,
2006). By using a theoretical framework, such as the Shannon Weaver Communication theory,
more studies may be conducted that might provide insight into the breakdown of communication
and the introduction of “noise” between the nurse and the patient.
For many hospitals today, patient satisfaction data are captured by the Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS) scores and are publicly reported.
This survey instrument was developed in partnership with the Center for Medicare and Medicaid
Services (CMS) and the Agency for Healthcare Research and Quality (AHRQ) and endorsed by
the National Quality Forum (NQF) (hcahpsonline.org, 2014). The public reporting of the
HCAHPS scores is designed to increase transparency and stimulate hospital incentives to
improve practices. One of the many questions posed to patients after discharge from the hospital
are their perceptions of the communication between the nurses and themselves. If scores are low,
it is difficult for hospitals to create quality improvement processes without first identifying the
areas of communication failures. Applying a communication theory to practice will help to
identify areas of “noise” leading to communication failures which may then lead to appropriate
quality initiatives.
One major criticism of the Shannon Weaver Communication model is that it was
originally designed for data transmission which has no meaning attached to it as opposed to
information sharing where the receiver attached meaning and emotion to the message (Stewart,
Malayan, & Roberts, 2001). This thought is echoed by Chandler (1994) who believes the model
reduces communication to the simple transmission of information where information has no
meaning. Haworth and Savage (1989) point out that the model focuses on the communication
skills of the sender and does not take into account non-verbal communication thereby ignoring
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the inferences the receiver may have assumed. Weaver defends this by stating that information
technologies, such as the telephone lines of communication are no longer simply technical
devices but are a metaphorical description of language in general (Day, 2000). Finally, Genosko
(2012) states that this model misses the concept of environment which shapes the senders and
receivers meanings of messages.
The Generalizability of the Theory
The Shannon Weaver Communication theory has greatly contributed to the advancement
of computer science (Chandler, 1994). The model has been widely adopted by many disciplines
including psychology, sociology, education, organizational analysis and nursing and is the most
widely used communication model due in part to its simplicity and generalizability (Chandler,
1994). According to Walker and Avant (2010) the more far-reaching a theory can be applied the
more generalizable it is.
Patient-centered care is defined as "Providing care that is respectful of and responsive to
individual patient preferences, needs, and values, and ensuring that patient values guide all
clinical decisions" (Institute of Medicine, 2001). Patient centered care first developed from the
work of Neuman and Young (1972) has as its core value collaboration with the patient (Hart,
2010).Collaboration with the patient allows the patient and family to participate in healthcare
decision making and requires effective communication skills (Hart, 2010). Shared decision
making by patients and families is encouraged by the Center for Medicare and Medicaid Services
(CMS) and whose language is included in the Affordable Care Act of 2010 (Lee & Emanuel,
2013). To achieve shared decision making all healthcare practitioners need to have effective
communication skills. With medical treatment options comes the decision to determine if
benefits outweigh any risks. This is particularly important when patients are approached to enroll
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into a research study that may pose additional risks they would not necessarily be exposed to.
Excellent communication skills by all healthcare personnel are needed to adequately inform
potential research participants of these risks and must include the ability for the research
personnel to assess for participant understanding. The use of the Shannon Weaver
Communication Theory will allow the investigator and other research personnel the ability to
transform their intended messages into language for lay persons to understand, assess for
understanding through the feedback process and increase the likelihood of the message being
delivered as intended.
The Testability of the Theory
For a theory to be considered valid, it must be tested (Walker & Avant, 2010). Nursing
knowledge development begins with theory testing; yet testing theories has been acknowledged
as being underutilized in nursing (McQuiston, & Campbell, 1997). “Theoretical thinking in
nursing uses concepts and their relationships to organize and critique existing knowledge and
guide new discoveries to advance practice” (Higgins, & Moore, 2000, p. 179). Although the
quest for nursing knowledge never ends, theoretical models offer an important viewpoint for
building a better understanding of nursing phenomenon (Carper, 1978). Bylund, Peterson, &
Cameron (2012) tell us that studies may be grounded with the use of a theory as a starting point
and additionally may add further explanation to the study’s findings. Many aspects of the
provider/patient relationship both verbal and nonverbal arise within the healthcare environment.
Communication theories need to be further tested in the healthcare arena to determine its value
and applicability and to add to the current state of the science. Although the Shannon Weaver
Communication Theory was not originally developed to describe interpersonal communication,
with the addition of the feedback loop, it appropriately describes interpersonal dialogue. To
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communicate effectively, we need to familiarize ourselves with the issues involved in the
communication process. Once we are aware of them, these issues will help to plan, analyze
situations, solve problems, and make process improvements (Lee, 1993). The use of the Shannon
Weaver theory will allow for this identification and analysis. Where there are untested theoretical
concepts it is prudent to test those relationships which will add to the body of knowledge
(Walker & Avant, 2010).
Significance to Nursing
Disciplines often share knowledge and borrow theories which continue to be transformed
as practice environments change (Reed & Shearer, 2011). An important function of nursing
practice is to communicate to patients and families about their illness and treatment options
(Kruijver, Kerkstra, Francke, Bensing, & van der Wiel, 2000). Another important
communication goal is to establish interpersonal relationships with patients in order to exchange
information, give explanations, and provide physical care (Caris-Verhallen, Kerkstra, & Bensing,
1997). Peplau described a theory of interpersonal relations between the nurse and the patient by
describing phases of the developing relationship (Caris-Verhallen, Kerkstra, & Bensing, 1997).
Although this theory explains the intimate and unique relationships nurses have with patients it
does not describe the nature or process of communication occurring within the relationship.
Other nurse theorists have described the nurse patient relationship as one that is dynamic such as
Orlando’s interaction theory (Orlando, 1961) and King’s interacting systems conceptual
framework (King, 1981). However, neither of these theories describes how communication is
channeled, by whom, what process and what happens when communicated messages fail. The
Shannon Weaver model, born out of technology and communication studies may provide a
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framework for the intimate messages shared in a bi-directional manner between nurses and
patients.
Conclusion
Critique of a theory highlights the theory’s strengths and limitations, identifies gaps,
questions existing knowledge and identifies areas for further testing (Silva & Sorrell, 1992).
Theoretical analysis consists of breaking down all the parts or concepts within the theory to
determine how they relate to each other. This allows for the examination of the validity of the
theory for its use in real world situations including need for further refinement (Walker & Avant,
2010). After analysis is complete the investigators may determine the theory’s potential
contribution to the discipline of nursing and the advancement of scientific knowledge (Walker
and Avant, 2010).
The Joint Commission revealed that miscommunication was the root cause 65-70% of the
time when analyzing more than 3000 sentinel events from 1995-2005 (Adamski, 2007). Not only
does effective communication decrease medical errors, it also improves patient satisfaction, and
better adherence to treatment plans leading to better health outcomes (Fink, Prochazka, & Wu,
2006). Communication between healthcare professionals facilitates the success of interventions
by promoting learning and new sense making (Jordan, Lanham, Crabtree, Nutting, Miller,
Stange, & McDaniel, 2009). In addition to miscommunication leading to medical errors it has
previously been described how miscommunication leads to lack of understanding of the risks,
benefits and other critical aspects of a research study. Therefore, communication, how we speak
to patients, potential research participants, the messages we send, the language we use all impact
how the received message is interpreted. Employing the feedback loop in the communication
process has been recommended as an effective method to improve patient understanding of
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medical information (Sayah, Williams, Pederson, Majumdar, & Johnson, 2014). Assessing for
patient understanding is a critical element of good communication. The Shannon Weaver
interpersonal communication theory with its feedback process from the receiver to the sender
may be a good theoretical framework for further research into empirical studies testing the teach
back method as interventions with different patient cohorts in different unique settings.
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Manuscript Two: Review of the Literature
For the second manuscript the Journal of Advanced Nursing was selected for submission
of a systematic review of the literature on interventions to improve research participants’
understanding of informed consent. As more and more hospitals are expecting nurses to become
involved in research, there is a large learning curve on the regulatory requirements around
informed consent for research. It is imperative that clinical nurses understand the significance of
participants’ lack of understanding when consenting to participate in research. Therefore, a
journal that is primarily published for nurses was chosen. For the purposes of this chapter, APA
format has been used to be consistent with all other chapters in this dissertation. Formatting, per
the journals’ requirements will be completed prior to submission.
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Abstract
The United States Department of Health and Human Services (DHHS) mandates that
informed consent information given to potential research participants be in a language and
reading level understandable to them. Despite this, it is common for consent forms to contain
structured and technical language to disclose participants’ rights, and responsibilities often
written at a college or graduate level. Significant misunderstandings about risks, benefits and
other aspects of research are misunderstood by as many as 24-74% of participants. The purpose
of this review is to systematically evaluate single, empirically tested interventions designed at
improving research participants’ understanding of informed consent.
Keywords: consent, informed consent, research, clinical trials, research participation,
research subjects, research understanding, research comprehension and interventions
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Introduction
In 1989 the United States Food and Drug Administration (FDA) joined Japan and the
European Union (EU) in founding the International Conference on Harmonization (ICH) of
Technical Requirements for Registration of Pharmaceuticals for Human Use. The purpose of the
ICH is to standardize the pharmaceutical development procedures when conducting human
subjects’ research. As part of this effort, the ICH has developed "Good Clinical Practice" (ICHGCP) guidelines including requirements for informed consent (Miller, 1997). These guidelines
clearly state the language used in both oral and written information about the clinical trial,
including the written informed consent form, should be as non-technical as practical and
understandable to the subject. (International Conference on Harmonization-Good Clinical
Practice, 2016). Despite this, it is common for consent forms to contain structured and technical
language to disclose participants’ rights, and responsibilities. Many studies have demonstrated
that consent forms are typically written at a college or graduate level, the same level one would
write for peers rather than lay persons (Buccini, Iverson, Caputi & Jones, 2011; Cheung, Pond,
Heslegrave, Enright, Potanina & Siu, 2010 ; Green, Duncan, Barnes, & Oberklaid, 2003;
Institute of Medicine, 2004). It is no wonder that as many as 24-74% of research participants
have significant misunderstandings about their research (Joffe, Cook, Cleary, Clark, & Weeks,
2001).
Several authors have previously conducted systematic reviews on participants’
understanding of research consent (Cohn & Larson, 2007; Dunn & Jeste, 2001; Falagas, Korbila,
Giannopoulou, Kondilis, & Peppas, 2009; Flory & Emanuel, 2004; Montalvo & Larson, 2014;
Nishimura, Carey, Erwin, Tilburt, Murady & McCormick, 2013; Palmer, Lanquette, & Jeste,
2012; Synnot, Ryan, Prictor, Featherstonhaugh, & Parker, 2014; Tamariz, Palacio, Robert, &
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Marcus, 2012). All of these reviews were restricted to selected publication years, research
designs, intervention type or a specific cohort. Therefore, the purpose of this review is to
systematically evaluate single, empirically tested interventions designed at improving research
participants’ understanding of informed consent for research and report on studies that may have
been previously excluded.
Methods
This review followed the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) method (Moher, Liberati, Tetzlaff, & Altman, 2009). An extensive
literature search was conducted using Medline, Ovid, PsycINFO, and Cumulative
Index to Nursing and Allied Heath Literature (CINAHL) databases. The following key words
were used in various combinations as Medical Subject Headings (MeSH) terms: consent,
informed consent, research, clinical trials, research participation, research subjects, research
understanding, research comprehension and interventions. Articles were retrieved if they
contained any of the key words as a main subject heading. Inclusion criteria were English
language, reports on empirical studies and publication in a peer-reviewed journal. Exclusion
criteria were informed consent for surgery or other procedures not specific to research
participation as this is not the aim of this review, research involving participants with a
psychiatric disorder or cognitively impaired as this aggregate do not represent the general
population, research conducted in emergent situations (such as the emergency room or during
labor), studies examining consent from legal guardians not directly participating in the research
as this is not the primary aim of this review and research involving children.
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After conducting an extensive review, 45 articles were abstracted. When reviewing the
references from all the articles, an additional 15 research studies were retrieved for a total of 60
articles.
Results
From the 60 articles retrieved, 27 were descriptive studies and 8 were systematic reviews
and therefore did not meet the inclusion criteria. The systematic reviews were not included as the
intent was to review single interventional studies described in more detail than traditionally

Identification

presented in a review. Twenty five studies met the inclusion criteria (see Figure 4).

45 records identified through
database searching

15 additional records identified
through other sources

Included

Eligibility

Screening

60 records identified after
duplicates removed

60 records screened

34 full text articles
accessed for eligibility

25 full text articles
included in synthesis

Figure 4. PRISMA Literature Search Process

45

26 descriptive/other
studies excluded

8 full text systematic
reviews excluded

Interventions
Articles describing interventions designed to improve participants’ understanding are
categorized as follows: 1. modifications to the informed consent form by simplifying the
language and/or the use of informed consent supplements (n = 12), 2. educational offerings for
research participants or investigators, (n = 2), 3. monetary rewards to participants as incentives
(n = 1), 4. communication techniques, (n = 4), and 5. the use of multimedia tools for consenting
(n = 6). The following is a report of these interventions in chronological order according to
publication date, within category. Each study was also evaluated for its strength and hierarchy of
evidence rating where levels range from I, Meta-analysis as the highest level to level VII, expert
opinion as the lowest, as described by Melnyk and Fineout-Overholt (2011).
Studies were conducted in several countries including Australia (n = 2), Canada (n = 1),
Denmark (n = 1), Finland (n = 1), France (n = 1), Malawi (n = 1), Netherlands (n = 1) and the
United States (n = 17). See Table 1 for all studies’ citations, intervention type and evidence
rating included in the review listed in alphabetical order by first author’s last name.
Modifications and/or Supplements to Standard Informed Consent Documents
Twelve studies focused on simplifying the language and other modifications to the
informed consent document or provided supplemental material to improve participants’
understanding (Bjorn, Rossel, & Holm, 1999; Campbell, Raisch, Sather, Segal, Warren, & Naik,
2008; Coletti, Heagerty, Sheon, Gross, Koblin, Metzger, & Seage, 2003; Coyne et al., 2003;
Davis, Holcombe, Berkel, Pramanik, & Divers, 1998; Dresden & Levitt, 2001; Juraskova et al.,
2008; Paris et al., 2007; Raich, Kennedy, Vanoni, Thorland, Owens, & Bennett, 2012; Stunkel,
Benson, McClellan, Sinaii, Bedarida, Emanual, & Grady, 2010; Sudore, Landefeld, Williams,
Barnes, Lindquist, & Schillinger, 2006 & Young, Hooker, & Freeberg, 1990).
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Young et al., (1990) studied a sample of 666 consumers who had used a mouthwash
product within the previous 3 months of enrollment into a hypothetical study. Part of the sample
read an informed consent document written at the 6th grade reading level and the other part of
the sample read a document written at the 10th grade reading level (as determined by the FleschKincaid readability formula). All participants were then given a 21-item investigator developed
questionnaire to ascertain their comprehension of the research study. Participants were told they
could take as much as 15 minutes to decide whether or not to participate in the study. There were
statistically significant higher comprehension scores between those participants who completed
the survey immediately after reading the consent and those participants who choose to think
about agreeing to participate or not for fifteen minutes. The participants were then divided into
educational levels as higher school or less, college, or graduate college level or more. There were
statistically significant improvements in comprehension the higher the educational level. The
authors do not state how subjects were assigned to receive either document, nor do they describe
the 21-item questionnaire used. This study used a quasi-experimental design and is an evidence
rating of Level III.
Other investigators modified study leaflets distributed by a major pharmaceutical
company, by reviewing the layout, style and language in order to improve participants’
understanding of the graphics, symbols, and content (Bjorn et al., 1999). Medical language was
replaced with lay language, long sentences were divided into additional, but shorter sentences
and long text was broken into smaller sections with headings and subheadings. The revised
leaflets, one describing a randomized clinical trial (RCT) for a hypertension study, and one
describing a complex RCT for a new anesthetic used during sterilization, were piloted to
ascertain participants’ understanding of the language, the symbols, and the message itself. One
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hundred thirty-five participants received the hypertension study leaflet and 100 received the
sterilization leaflet. The authors had participants complete the Summative Cognitive
Understanding Scale (developed by the authors) where there was a statistically significant
improvement in understanding with both revised leaflets compared to the original leaflets (Bjorn,
et al., 1999). This study used a randomized sampling technique which makes this level of
evidence II.
Coletti et al. (2003) enrolled and randomized Human Immunodeficiency Virus (HIV)
research participants into a hypothetical HIV study to evaluate the use of a prototype informed
consent process. Randomization of sampling makes this study a Level II. Those in the
intervention group received full disclosure of study information, an informed consent document
written at 8th grade reading level with enhanced visual displays, intense educational session at
the time of consenting and a booster educational session 6 months later, with a nonphysician/non-investigator obtaining consent. This intervention had a statistically significant
higher level of comprehension of key concepts in the informed consent document. Participants’
understanding was evaluated using the knowledge questionnaire, developed by the investigators,
where statements are written as true/false causing even those patients who do not know the
correct response, a 50% chance of getting the correct answer. The authors do not report any
psychometric properties of the instrument.
Sudore et al. (2006) conducted a study to assess research participants’ understanding of a
short, comprehensive written informed consent document by administering a simple 7-item
true/false question after participants had the document read to them and had read it for
themselves with all of their questions answered. Participants were recruited from a general
medical clinic and were given 3 attempts at providing all correct answers on the test. In addition,
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the authors administered the Short Form Test of Functional Health Literacy in Adults (STOFHLA) measurement of literacy. Sociodemographic variables including age, gender,
ethnicity, income and educational attainment were also collected. Only 28% of the participants
answered all 7 questions correctly at the first pass. The authors concluded that low literacy and
being black were statistically significant indicators for requiring more attempts at passing the test
(Sudore et al., 2006). This study used a descriptive design with no random sampling and is a
Level IV.
Campell et al. (2008) (Level II study) studied the use of a clinical trial handbook as a
supplement to the standard informed consent document in 146 patients recruited from an
outpatient clinic in the Veterans’ Affairs Health Care System. Participants were randomized to
receive the standard informed consent document (n = 62) or the clinical trials handbook (n=84).
The handbook, developed by experts in research conduct was a full color book explaining the
basic elements of informed consent for research and was edited until a seventh grade reading
level was achieved. Participants were asked to rate their understanding of their clinical trial on a
Likert scale where very clear = +2, to very confused = -2. There was a statistically significant
improvement in the intervention group including improved understanding of the option to stop at
any time, side-effects of the experimental treatment, randomization and voluntariness. The use of
a handbook as a supplement to informed consent seems promising, but these authors do not
describe the data collection instrument used, but rather, state they modified an existing
instrument.
Juraskova et al. (2008) supplemented the standard informed consent document with a
decision aid (DA) and received feedback on the DA by conducting semi-structure telephone
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interviews from thirty-one Australian women participating in a breast cancer clinical trial. The
survey given to participants had been developed by the investigators following an extensive
literature review, drafts, and editorial revisions, review by a team of investigators and pilot tested
with healthy volunteers. The authors do not report the survey’s psychometric properties.
Participants reported the DA assisted them in understanding their research study, with 80% of
the women answering the purpose and methods of the study correctly. The concepts of
randomization and blinding were still poorly understood despite the use of the DA. This was a
descriptive, Level IV study.
Other investigators have also simplified the informed consent document comparing them
to standard consent forms. Coyne et al., (2003) compared standard consent forms to a revised
consent form. Revisions included changes made to the text style, page layout, font size, and
vocabulary. Readability was reduced to the seventh to eighth-grade level. Assessment of
understanding was obtained by telephone interviews from trained interviewers to participants.
Twenty-three true/false and multiple choice questions were asked of participants, but the authors
do not describe the instrument. There was no significant improvement in understanding between
either the standard or revised informed consent form. The participants in this study were
randomized to the standard or simplified consent form making this study a Level II.
A similar study was conducted by Davis et al., (1998). The investigators compared a
standard consent form with a 16th grade level to a revised form with a 7th grade reading level.
Participants were then interviewed to complete a structured, oral 22-question survey to assess
for comprehension. Although participants preferred the revised form, there was no significant
improvement of understanding between the two groups. The authors do not describe
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randomization of subjects for this study but did test an intervention giving this study a quasiexperimental, Level III rating.
Dresden & Levitt (2001) randomized participants to receive either a standard or a
shortened informed consent form. Participants read the consent forms and then answered a 13question multiple choice test. Reliability and validity of the test is not stated by the authors. The
group with the shortened consent form had significant improvements in understanding of such
concepts of purpose of the study, study duration, randomization, risks, benefits, alternative
treatments and voluntary participation. Again, with randomization this is a Level II study.
Paris et al. (2007) randomized (Level II study) 200 healthy volunteers to one of 4
different versions of the informed consent form: a standard form, a consent form with systematic
lexico-syntactic readability improvement, a consent form modiﬁed by a working group, and a
consent form modiﬁed by the working group followed by systematic lexico-syntactic
improvement. Participants were then asked to discuss what they had read as if they were
explaining the study to a family member. No questions were asked by the investigator.
Participants’ responses were tape-recorded. Additionally, participants then completed the QCFic,
the French adaptation of the Quality of Informed Consent survey. Significant improvements
were evident in the group which read the consent form modified by working group compared to
the other three. Exact details of the four consent forms were not described.
Another study compared standard consent forms to a modified consent forms (Raich et
al., 2012). One hundred sixty-two male veterans were randomized to receive either the standard
or the modified consent form. Telephone interviews were conducted 2 weeks later to assess
participants’ understanding using 22-item true/false and multiple choice questions. The standard
consent form had a Flesch-Kincaid reading grade level of 7.9 where the modified consent form
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had a Flesch-Kincaid reading grade level of 5.6. The group with the modified consent form
demonstrated significant improvement in understanding. The authors conclude that modifications
including reading level format and appearance improve understanding of key elements of
consent. This study was a randomized controlled trial giving it a Level II rating.
Stunkel et al. (2010) randomized healthy volunteers to read either a standard or a concise
modified consent form. Comprehension was assessed by a quantitative instrument developed by
the authors. There was no difference in comprehension between the 14 page consent form or the
4 page consent form. The authors conclude that too much emphasis is spent on the details in the
consent forms, possibly due to a fear of legal liability issues. The strength of evidence for this
study is high due to the randomization of the sample. This is a Level II study.
Education
Two studies were found that used education as the intervention. Sengupta, Lo, Strauss,
Eron, & Gifford (2011) evaluated informed consent understanding among 24 recently enrolled
(within 1 month) HIV research participants. Participants who scored 85% or lower on the
Quality of Informed Consent instrument (n = 21) were randomly assigned to receive either a
targeted educational intervention or a delayed educational intervention in the Level II study. The
intervention included providing participants with the consent form and a question and answer
period lasting 20 minutes. Participants’ understanding improved with the targeted intervention as
compared to the delayed intervention. Understanding was assessed using the Quality of Informed
Consent (QuIC) instrument, a valid and reliable tool. The authors, however, edited the tool,
making many modifications to the instrument and deleting some questions.
Ndebele, Wassenaar, Munalulu, and Maslye (2012) conducted a Level II study to
evaluate an educational offering among research participants’ who had low scores in a previous
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study that assessed their understanding of informed consent. For participants who scored less
than 70% on the 3 concepts of randomization, double-blinding and placebo use, 18 were
randomized to standard informed consent process and 18 were randomized to receive additional
education. The educational intervention included a narrative on the study, translated into
participants’ Native language, ChiChewa, as well as a power point presentation with pictures
explaining personal implications to the study. Thirteen of the 18 women scored greater than 75%
on the post evaluation. There was a statistically significant increase in understanding of the 3
concepts within the intervention group when compared to the standard group. However, the
authors neither describe the validity of the translated language nor the data collection instrument.
Results should be replicated with these limitations addressed.
Monetary rewards
One study offered participants a monetary reward as an incentive to comprehension of
the informed consent material. Apseloff, Kitzmiller, & Tishler (2013) conducted a study to
determine if receiving a stipend as a reward would increase research participants’ understanding
of informed consent. Thirty healthy volunteers participating in a clinical trial were administered
a questionnaire to evaluate their understanding of the informed consent form. Many subjects
failed to comprehend a variety of basic concepts in the consent form directly impacting their
clinical trial participation. The specific questions asked were related to the number of blood
draws, whether the drugs in the study were experimental or not, the number of overnight hospital
stays required by the study, the likelihood of them receiving a placebo, their right to withdraw
from the study and other elements including if they felt the informed consent document difficult
to understand. Demographic information including education, annual income, and employment
status was also collected. Although only 13% felt the informed consent form difficult to

53

understand, a large percentage failed to comprehend many of the basic concepts of their clinical
trial, including 33% not knowing if the study drug was experimental or not. However, 97% did
know their chances of receiving a placebo. The sample size was small, however, and selected
from a pool of healthy trial participants. In addition, the authors do not disclose the reading level
of the informed consent document, therefore, we do not know the readability of the document.
This was a descriptive, Level IV study.
Communication
Four studies empirically tested altered methods of communication that focused on either
the investigator or the participants. Simes, Tattersall, Coates, Raghavan, Solomon, & Smartt
(1986) randomized participants to either receive an individual discussion with the
physician/investigator or the standard policy of total disclosure of all information in a Level II
study. The participants in the individual approach group received information on the study’s
aims, expected results and potential risks to treatment. The total disclosure group was told the
aim of the study, the chance of success, the experimental nature of the study, randomization,
alternate treatments, possible side-effects, and the ability to withdraw without penalty. Both
groups were given the opportunity to ask questions. Following this, each participant completed a
questionnaire specifically designed for this study. Analysis was performed on 55 participants.
Participants in the total disclosure group were much more knowledgeable about their illness and
treatment as well as side effects of treatment, the research nature of the study, and
randomization. This study would suggest that more information leads to better understanding.
However, the illness severity of the participants as well as how new they may have received a
devastating cancer diagnosis may play a factor in their abilities to comprehend new information.
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In a study by Aaronson et al. (1996), 180 cancer patients were approached to participate
in an oncology research study and randomized to receive either standardized informed consent
procedure which included a discussion with the physician and a standard informed consent
document (control group), or standard informed consent procedure plus a telephone conversation
as a supplement from an oncology nurse (intervention group). The nurses making the telephone
interviews were trained in telephone interviewing techniques, although this training is not
described in detail and inter-rater reliability for this intervention was not measured. The
intervention group had a statistically significant better understanding of risks and side-effects of
the treatments, the context of the treatments, the purpose of the research study, the concept of
randomization, the availability of alternative treatments, the voluntary nature of the study, and
the right to withdraw from the study at any time (Aaronson et al., 1996). The authors conclude
that this is a rather simple intervention to improve research study participants’ understanding of
key elements of their research study in this Level II, randomized study.
Hietanen, Aro, Holli, Schreck, Peura, & Joansuu, (2000) provided a short communication
course to physicians and nurses enrolling participants into a breast cancer research study.
Hospitals that were currently conducting a breast cancer study were randomized to be either the
control group which did not receive the communication course, or the experimental group which
received the short, one day communication course. The experimental group received training
from a facilitator experienced in training physicians in communication and included
psychological reactions to disease, interviewing techniques and the current research
demonstrating research participants’ lack of understanding. The lecture was followed by roleplaying as both the healthcare provider and the potential research participant. Demographic data
were collected from both groups. Three and half months after the communication course,
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research participants were surveyed with the Quality of Informed Consent (QuIC) instrument to
assess their understanding. Three hundred twenty surveys were mailed, with 288 (90%)
responding. Participants in the intervention group were statistically more satisfied with the
communication they received when enrolling into their study. Both groups felt they received
enough information to make an informed decision. Participants in the intervention group felt they
had been given sufficient time to make a decision, and had a statistically significant increase in
the understanding of the purpose of the study and the comparison of two study arms. The authors
also sought feedback from the staff who took the communication course. The physicians and
nurses all felt the training was very valuable and 80% wished the training had been longer. The
investigators concluded that the short communication course could be improved upon and be
valuable for those obtaining informed consent for research. Randomization makes this study a
Level II.
Kripalani, Bengtzen, Henderson, & Jacobson (2008) conducted a study of low income,
inner city African Americans participants recruited from a Primary Care Clinic. The participants
had previously consented to participate in a research study on medication adherence with
Coronary Artery Disease and had been randomized to receive or not receive teach back methods
when explaining their study to them making this a Level II study. Those participants in the teach
back experimental group were asked to explain back to the investigator key elements of their
research study. The ability for patients to teach back information ranged from 57.1% to 92.5%
with lower rates among the elderly and those will lower literacy. The authors concluded that
teach back allowed investigators to assess participants’ understanding in real time. The author
suggests that participants with low literacy should be considered a vulnerable population.
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Multi-media
Six studies empirically tested the use of multi-media aids. The term multimedia is used
when two or more forms or channels of communication are used conjointly such as the use of
voice and other sound, visual still pictures with motion pictures or computer based
communication (Palmer et al., 2012). Agre and Rapkin (2003) did not find an improvement in
research understanding when comparing informed consent delivered by booklet, videotape or
computer. The authors hypothesized that media tools would lead to better understanding of
informed consent for participants in high risk research studies; however, this was not supported
statistically. This study chose an interesting population from which to draw its sample. The
sample included a total of 441 individuals, 204 whom were patients at a Day Surgery Center, 109
were family members and 128 participants, the authors called “surrogate subjects” who were
individuals waiting for patients in the hospital’s waiting room. Randomized participants’
understanding was evaluated on a 12-15 multiple choice knowledge questionnaire developed by
the authors for this Level II study. The authors concluded that no one in any of the three groups
were able to correctly answer more than two thirds of the knowledge questions on the
investigator’s developed survey. As one third of the population was individuals in the waiting
room, these results may refute the belief that a devastating cancer diagnosis or other health issues
potential impact on the ability to comprehend the information in the informed consent document.
Reliability and validity of the survey tool used for this study is unknown.
Informed consent consultation audiotapes were compared with standard informed consent
audiotapes in a group of 69 women newly diagnoses with breast cancer in a study by Hack et al.,
(2007). All participants received standard research consent consultations and then randomized to
receive one of the types of audiotapes, or both. Outcomes were assessed using the Informed
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Consent Questionnaire adapted by the authors for this study which includes two subscales: The
Patient Perception of Being Informed (PPBI) subscale and the Patient Knowledge of Information
Relevant to Informed Consent to Clinical Trials (PKI). There were no statistically significant
differences in participant knowledge of or perceptions of being informed with the consultation
audiotape. The authors admit their study is limited by its small sample size and lack of a control
group. This study was a Level II a Randomized Controlled Trial.
Bickmore, Pfeifer, and Paasche-Orlow (2009) randomized (Level II) the use of a
computer agent, versus human communication, versus self-study information on potential
research participants understanding of informed consent for a hypothetical study. Twenty-nine
subjects were recruited from a university neighborhood mostly occupied by elder, minority
adults. Participants’ understanding was assessed using the Brief Informed Consent Evaluation
Protocol (BICEP). While completing the BICEP, participants were allowed to refer to the paper
copy of the informed consent document. The investigators also measured participants’ health
literacy using the Rapid Estimate of Adult Literacy in Medicine (REALM) which has previously
demonstrated reliability and validity. Participants were then given either the computerized agent
after a brief session on how to use the computer, human communication about informed consent
for research or a written informed consent for them to read (with as much time as they needed to
read it). The human conversation for informed consent was completed by a research assistant
with experience in this area. Thirteen of the 29 participants (45%) had poor health literacy
(defined as reading at 8th grade level or below). Analysis revealed that for those participants who
had adequate health literacy, there was a statistically significant improvement in comprehension
with both the computer agent and human conversation. For those participants with inadequate
health literacy, there was no statistically significant difference with comprehension among the
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three interventions. The authors recognize this study’s generalizability is limited due to the small
convenience sample used. These authors do not describe if participants were randomized into
either intervention groups or the control group, we therefore do not know the sampling strategy.
Kass et al., (2009) also tested the use of a video for improving research participants’
comprehension of informed consent. The investigators drew their sample from Oncology patients
in a large metropolitan area, where participants were randomly assigned to either the intervention
group where they watched a 20 minute video on clinical trials or the control group which
received an information pamphlet developed by the National Cancer Institute. The video
included 5 actors playing the role of patients deciding whether or not to enroll in a research
study. Two hundred eighty-eight were randomized to receive the video with 130 completing the
survey questionnaire. Of the 130 who completed the survey, 70 received the computer based
video and 60 received the pamphlet. A trained investigator interviewed each of the participants
to garner their knowledge about the purpose, risks and benefits of their study using a structured
questionnaire developed by the investigators. Participants in the intervention group were
significantly more likely to understand the purpose of the research study. Interestingly, there was
no statistically significant difference between the two groups for participants’ beliefs about how
enrolling in the trial would impact their cancer.
In a study by Hoffner, Bauer-Wu, Hitchcock-Bryan, Powell, Wolanski, & Joffe, (2012)
the authors tested the intervention of a video designed to prepare cancer patients with their
decisions about potential research enrollment. Ninety cancer patients were randomly assigned to
receive the video (intervention group) or the standard informed consent process (control group).
The participants completed the Quality of informed Consent (QuIC) instrument, a valid and
reliable tool, to assess their understanding of the key elements of their research study. All
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participants also completed additional questions on their satisfaction with the video and
patient/provider communication. There was no statistically significant difference between the
groups with objective understanding of informed consent for research. The majority (85%)
however, felt the video was an important source of information, and 81% felt they were better
prepared to discuss the research study with their physician (Hoffner et al., 2012).
McGraw, Wood-Nutter, Solomon, Maschke, Benson, & Irwin (2012) pilot tested video
vignettes 20 minutes in length with captions and narration after receiving input into its
development by six African Americans and six non- Hispanic white individuals for clarity and
content. Patients visiting several local Oncology clinics were recruited to participate.
Recruitment was specifically designed to capture a widely diverse group of racial and ethnic
backgrounds and educational levels. Forty-three participants were randomized to read an
informed consent document or view the multi-media video with vignettes, then participate in a
semi-structure interview. Twenty-two of the 32 participants (68%) who viewed the video felt it
to be very useful and provided them with enough information to make an informed decision. Ten
participants, however, felt the video alone was not enough and asked for additional resources.
The most common complaint about the video was the length. Participants felt it too lengthy and
tedious, especially the parts of the video that spoke about the role of the Institutional Review
Board (IRB). Both groups had a good understanding that the benefits of research was primarily
for future patients. Although more than half of the participants knew they might be contacted for
future research, less than one fifth said they would refuse to participate, leaving the investigators
to wonder if they did not fully appreciate the voluntary nature of research participation. This
study’s design and sampling make is a Level II.
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Discussion
Studies assessing research participants’ understanding of their specific study, have
identified issues with lack of comprehension. This problem has been researched and described
for more than twenty-five years. Several approaches have been taken to improve research
participants’ understanding, which included altering the language in the informed consent
document, providing supplemental information or additional education, or the use of multi-media
tools or altered communication techniques.
Several systematic reviews on interventions to improve research participants’
understanding of informed consent have previously been published but were limited to
publication years (Dunn & Jeste, 2001; Cohn & Larson, 2007; Montalvo & Larson, 2014),
research design (Nishimura et al. (2013), intervention type (Palmer et al., 2012; Synnot et al.,
2012), or specific cohort (Tamariz et al., 2012). This systematic review addressed these gaps but
not applying those exclusionary criteria, but rather taking a more inclusive review of current
research.
Each of the 25 studies reviewed were rated according to the hierarchy of evidence
described by Melnyk and Fineout-Overholt (2011). The majority of the studies (n = 20) were
Level II, a single randomized study. Two studies were Level III, due to non-randomization of the
sample and 3 studies were Level IV, descriptive. Although all of the studies described research
design and sample selection, none of the studies explained how the investigators arrived at their
sample size. The authors acknowledged when they had a small sample which begs one to wonder
why an a priori power analysis was not done. Therefore, it would appear as though many of
these studies, though well designed might be underpowered. If this is the case, the results must
be viewed with caution. Additionally, none of the communication studies was longitudinal and
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therefore it is unknown whether a change in communication patterns and methods can be
sustainable over time.
There are instruments currently available to measure research participants’ understanding
that have demonstrated reliable psychometric properties (Joffe et al., 2001; Sugarman, McCrory,
Powell, Krasny, Adams, Ball, & Cassell, 2005). Despite this, only 6 studies used a valid and
reliable instrument to gather quantitative comprehension scores. The majority of studies were
conducted with instruments developed by the authors. A major limitation of these studies
therefore, is the unknown reliability and validity of the instruments. This jeopardizes the internal
consistency of the study and limits the generalizability of the results. Other research used
hypothetical studies which begs one to wonder if participants would be less concerned with risks
involved in enrollment, knowing the study is not actually occurring. The majority of the studies
examining participants’ understanding did so several weeks to months after the informed consent
discussion which may introduce recall bias. Some studies have admittedly recruited a small
sample size, and therefore may be underpowered. Results should be interpreted with caution
Lastly, the use of a theoretical framework supporting empirical research on informed
consent has been absent from the literature. Meade (1999) suggests researchers look towards
communication or adult education for theoretical frameworks to support future studies. Although
none of the studies described in this review reported on the use of a theoretical framework it is
believed that an intervention is more likely to be effective if based on a model or theory (Conn,
Rantz, Wipke-Tevis, & Maas, 2001).
Limitations
This review set out to be more inclusive of the literature than previously published
reviews; however it does have some limitations. First, it only included articles which have been
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published in English. Although a comprehensive literature search was conducted, it is possible
that some relevant articles may have been missed. Abstract presentations, dissertations and
unpublished work are not reported here which may result in reporting bias.
Conclusions
More research is needed that addresses the limitations of the studies described in this
review. Well-designed research studies with support of a theoretical framework, use of valid and
reliable instruments, a randomized sampling strategy and enrollment of a large enough sample to
have adequate power to determine statistical significance may yield interesting results and allow
for strategies to improve participants’ understanding to be implemented into practice. Without
well-designed studies demonstrating reliable interventions for improving research participants’
understanding this 25 year old problem will persist.
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Table 1. Citations in Systematic Review
Citation

Intervention

Aaronson et al. (1996). Telephone-based nursing interventions
improves the effectiveness of the informed consent process in cancer
clinical trials. Journal of Clinical Oncology, 14, 984-996.

To test a telephone intervention
to increase participants’
understanding of their clinical
trial.

Communication

Agre, P., & Rapkin B. (2003). Improving informed consent: A
comparison of four consent tools. IRB: Ethics & Human Research,
25(6), 1-7.

To measure the effectiveness of
videotape, computer, and booklet
format-against the standard
written consent form.

Multi-media

RCT
Level II

Apeseloff, G., Kitzmiller, J.P., & Tischler, C. L. (2013). Credibility
and comprehension of healthy volunteers in lengthy inpatient drug
studies.

To assess motivation,
comprehension and the effects of
offering a stipend on knowledge
of clinical trial.

Monetary Reward

Descriptive
Level IV

Bickmore, T.W., Pfeifer, L.M., & Paasche-Orlow, M.K. (2009).
Using computer agents to explain medical documents to patients
with low health literacy. Patient Education Counseling, 75(3): 315320.

To evaluate an animated
computerized agent to explain
research consent forms to
potential research participants

Multi-media

RCT
Level II

Bjorn et al. (1999). Can the written information to research subjects
be improved? An empirical study. Journal of Medical Ethics, 25,
263-267.

To determine if changes made to
information leaflets from clinical
trials improved perceived
difficulty and understanding of
the content.

Modifications to the
Informed Consent
Document

RCT
Level II

Campbell et al. (2008). Impact of a clinical trials information
handbook on patient knowledge, perceptions, and likelihood of
participation. IRB: Ethics & Human Research, 30(1), 6-14.

To assess an Informed Consent
Handbook on participants’
understanding of informed
consent.

Modifications to the
Informed Consent
Document

RCT
Level II
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Purpose

Evidence
Hierarchy
RCT
Level II
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Coletti et al. (2003). Randomized, controlled evaluation of a
prototype informed consent process for HIV vaccine efficacy trials.
Journal of Acquired Immune Deficiency Syndrome, 32, 161-169.

To test a prototype informed
consent process to improve
participant understanding

Modifications to the
Informed Consent
Document

RCT
Level II

Coyne et al. (2003). Randomized, controlled trial of an easy to read
informed consent statement for clinical trial participation: A study of
the Eastern Co-operative Oncology Group. Journal of Clinical
Oncology, 21(5), 836-842.

To evaluate a modified easy to
read informed consent document
on patient anxiety, satisfaction
and understanding of their
clinical trial.

Modifications to the
Informed Consent
Document

RCT
Level II

Davis et al. (1998). Informed consent for clinical trials: A
comparative study of standard versus simplified forms. Journal of
the National Cancer Institute, 90(9), 668-674.

To compare a standard consent
written at 16th grade reading level
to a simplified form written at 7th
grade reading level.

Modifications to the
Informed Consent
Document

Quasiexperimental
Level III

Dresden, G. M. & Levitt, A. (2001). Modifying a standard industry
clinical trial consent form improves patient information retention as
part of the informed consent process. Academic Emergency
Medicine, 8(3), 246-252.

To ascertain patient retention of
information from an industry
sponsored consent form
compared to a condensed,
simplified form

Modifications to the
Informed Consent
Document

RCT
Level II

Hack et al. (2007). Standardized audiotape versus recorded
consultation to enhance informed consent to a clinical trial in breast
oncology. Psycho-Oncology, 16, 371-376.

To compare two audiotape
formats for the delivery of
informed consent to

Multi-media

RCT
Level II

Hietanen, et al. (2007). A short communication course for physicians
improves the quality of patient information in a clinical trial. Acta
Oncologica, 46, 42-48.

To determine if a communication
course would improve
participants’ understanding of
their clinical trial.

Communication

RCT
Level II

Hoffner et al. (2012). Entering a clinical trial: Is it right for you? A
randomized study of the clinical trials video and its impact on the
informed consent process. Cancer, 118(7), 1877-1883.

To assess an educational video in
preparing cancer patients for
enrollment into a clinical trial

Multi-media

RCT
Level II
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Juraskova et al. (2008). Improving informed consent: Pilot of a
decision aid for women invited to participate in a breast cancer
prevention trial (IBIS-II DCIS). Health Expectations, 11, 252–262.

To pilot test a decision aid
booklet to improve participant
understanding of informed
consent

Modifications to the
Informed Consent
Document

Descriptive
Level IV

Kass et al. (2009). An intervention to improve cancer patients’
understanding of early phase clinical trials. IRB: Ethics & Human
Research, 31 (3), 1-10.

To test a computer-based tool and
pamphlet with cancer patients
who were considering enrolling
in an early-phase clinical trial.

Multi-media

RCT
Level II

Kripalani S, Bengtzen R, Henderson L, & Jacobson T. (2008).
Clinical research in low-literacy populations: Using teach back to
assess comprehension of informed consent and privacy information.
IRB: Ethics & Human Research, 30 (2), 13-19.

To examine the association of
patients’ age, cognition, years of
education, and literacy level with
comprehension of informed
consent

Communication

RCT
Level II

McGraw et al. (2012). Clarity and appeal of a multi-media informed
consent tool for biobanking. IRB: Ethics & Human Research, 34(1),
9-19.

What information regarding
domains of informed consent in
the multimedia tool and written
consent document was salient to
the participants

Multi-media

RCT
Level II

Ndebele, P.M., Wassenaar, D., Munalula, E., & Masiye, F. (2012).
Improving understanding of clinical trial procedures among low
literacy populations: An intervention within a microbicide trial in
Malawi. BMC Medical Ethics, 13, 29

To assess participants’
understanding of randomization,
double-blinding and placebo use.

Education

RCT
Level II

Paris et al. (2007). Improvement of the comprehension of written
information given to healthy volunteers in biomedical research: A
single-blind randomized controlled study. Fundamental & Clinical
Pharmacology,21, 207–214.

To identify if improvement in
lexico-syntactic readability could
increase comprehension of
information given to volunteers
enrolled in biomedical research

Modifications to the
Informed Consent
Document

RCT
Level II

To assessed the impact of an
informed consent process

Modifications to the
Informed Consent
Document

RCT
Level II

Sengupta, S., Lo, B., Strauss, R.P., Eron, J., & Gifford, A.L. (2011).
Pilot study demonstrating effectiveness of targeted education to
improve informed consent understanding in AIDS clinical trials.
AIDS Care, 23(11), 1382-1391.

To pilot test an educational
intervention to improve actual
informed consent understanding

Education

RCT
Level II

Simes, R.J., Tattersall, M.H., Coates, A.S., Raghavan, D., &
Solomon, H.J. (1986). Randomized comparison of procedures for
obtaining informed consent in clinical trials of treatment of cancer.
British Medical Journal, 293, 1065-1068.

To compare 2 methods of consent
to randomized treatment.

Communication

RCT
Level II

Stunkel et al. (2010). Comprehension and informed consent:
Assessing the effect of a short consent form. IRB: Ethics & Human
Research, 32(4), 1-9.

To evaluate the effect of a shorter
and simpler consent form on the
comprehension of research
participants.

Modifications to the
Informed Consent
Document

RCT
Level II

Sudore et al. (2006). Use of a modified informed consent process
among vulnerable patients: A descriptive study. Journal of General
Internal Medicine, 21, 867-873.

To determine whether literacy
and demographics are associated
with understanding consent
information.

Modifications to the
Informed Consent
Document

Descriptive
Level IV

Young et al. (1990). Informed consent documents: Increasing
comprehension by reducing reading level. IRB: Ethics & Human
Research, 12(3): 1-5.

To understand the impact of
Modifications to the
informed consent reading level on Informed Consent
subjects’ comprehension.
Document
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Raich, et al. (2012). Improved understanding and satisfaction with a
modified informed consent document: A randomized study. Patient
Intelligence, 4, 23-39.

Quasiexperimental
Level III
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Chapter Summary
This chapter included two manuscripts for submission for publication. The first
manuscript is a critique to the Shannon-Weaver Communication theory. The Shannon-Weaver
Communication theory may serve as a framework for future nursing studies employing teach
back, patient hand-offs or other aspects of nursing communication. A thorough critical review of
the theory is warranted if it is to be applied to nursing and a critique of this theory has not
previously been published.
The second manuscript describes a systematic review of the literature to examine
interventions tested to improve research participants’ understanding of informed consent. This
systematic review describes interventions previously tested and allows the reader to understand
the depth and breadth of the issue and various methods attempted at making improvements in
research participant understanding. Armed with this information the following chapter describes
the research design used to test the teach back method of communication for improvements in
research participants’ understanding of informed consent.
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CHAPTER 3 METHODS
The research questions, hypotheses, methods, design, sampling strategies, intervention
and data collection and analytical methods used for this study are presented in this chapter. Also
included are limitations and processes for protection of human subjects. The teach back process
of communication intervention is described.
Research Questions and Hypotheses
The research questions driving this study were 1. In research participants, will the use of
the teach back method of communication compared to standard language, improve objective
understanding of informed consent? 2. In research participants, is the relationship between
objective and subjective understanding different in the control group (standard communication)
compared to the experimental group (teach back communication)?
The following hypotheses were proposed for testing in this study: participants will have a
greater understanding of the risks, benefits and other key elements of their research study after
receiving the teach back process of communication. A secondary hypothesis is that there will be
less of a difference between objective and subjective understanding within the experimental
group.
Methods
Design
This study used a quasi-experimental sequential two group design with pre and post
intervention groups. The pre-intervention group served as the control group and the post
intervention group, the experimental group. This design was chosen as it was impractical in the
clinical setting to randomize the participants.
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Setting
This study was conducted at a large, tertiary care hospital in New England. The hospital
serves as a major cardiology referral center for the state. The Cardiology department is actively
participating in 7 national clinical trials.
Sample
This study used a convenience sample of 52 adult Cardiology patients (38 for the preintervention group and 14 for the post intervention group) identified by the Cardiology Research
Coordinators when accessing their database for potential Cardiology clinical trial participants.
The sample was drawn from participants in two cardiac clinical trials that were open at the time
of recruitment. Inclusion criteria were English speaking and writing and enrolled in a cardiac
clinical trial. Exclusion criteria were: 1) under the age of 18 years, 2) a current diagnosis of
dementia, Alzheimer’s or who are otherwise cognitively impaired or diagnosed with a mental
illness, and 3) participation in a research study where assent was given by a legal guardian or
someone other than the participant themselves.
A total of 74 participants was targeted as the sample size (A1 Therapy Statistics, 2016).
To determine sample size, Cohen (1988) states there is a β of .2 or a 20% probability of failing to
detect an effect when there is one (a Type II error). Therefore there is 1-β or a .8 or 80%
probability of detecting an effect when there actually is one. The last number needed to
determine a power analysis is the effect size. According to Cohen (1992), a small effect size is (r
= .1), a medium effect (r =.3) and a large effect size (r = .5).
Only one prior research study has tested the use of the teach back process of
communication as an intervention to improve research participants’ understanding of informed
consent (Kripalani et al., 2008). According to Hulley, Cummings, Browner, Grady, & Newman
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(2007) when there is no a priori data on which to establish the effect size, the investigator may
conduct a pilot study. Field (2011) suggests in the absence of prior research, the researcher needs
to estimate the likely effect size based on similar studies. For this study the effect size was
estimated to be large. Therefore, with an α of .1, power of .8 and effect size of .5, the estimated
sample size for this study was 37 participants in each group.
Measurement
Participant Demographics. Demographic data were collected to describe the subjects.
This included age, gender, socio-economic status and educational level.
Socioeconomic Status. It is believed that participants’ socioeconomic status as measured
by their educational level and income may impact their ability to read and understand their
informed consent document. This may or may not have an impact on their ability to understand
and comprehend the research study in which they are participating and therefore was collected
and analyzed as a confounding variable. Socioeconomic status was measured by household
income as defined by the United States Census Bureau. Years of completed education was
collected as it may have an impact on participants’ ability to read and understand the informed
consent document. This can be found in Appendix C.
Instrument. The Quality of Informed Consent (QuIC) instrument was developed by
Joffe et al. (2001). The overall purpose of the instrument was to evaluate participants’
understanding of their clinical trial. The authors started with the basic elements of informed
consent outlined in federal regulations (Code of Federal Regulations, 2012). These included
elements such as the voluntary nature of the research, the risks and benefits, the use of Protected
Health Information, the cost to the participant as well as other key points that must be in the
consent form. However, some of these elements (such as “benefits to the subject or to others”)
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are actually a synthesis of two or more different concepts and therefore, Part A of the QuIC
contains 20 questions that include 13 distinct domains of informed consent measuring objective
understanding. Questions are answered on a Likert scale from 1 (disagree), 2 (unsure) and
3 (agree). Each correct answer in Part A is given a score of 100 points, an “Unsure” response is
given a score of 50 points and incorrect answers are given 0 points. Unanswered questions are
not scored.
Part B of the instrument measures subjective understanding which assesses what
participants believe they understand (Joffe et al. 2001). Part B of the instrument contains 14
questions answered on a Likert scale from 1 (I didn’t understand this at all), to 5 (I understood
this very well). Part B of the QuIC is scored by taking the average responses to each of the
fourteen questions and scaled from 0-100 (summary score = raw average -1 x 25). This allows
for equal weighting among the domains in the instrument.
Part A of the instrument, participants’ objective understanding was the primary outcome
variable of interest in this intervention study. It was hypothesized that participants believe
themselves to be informed when in reality are not. This hypothesis is supported by previous
research where as many as 90% of participants were satisfied with the informed consent process
and believed themselves to be fully informed, but when questioned in more detail, were unaware
of the purpose of the study, the unproven nature of the intervention and other aspects of their trial
(Joffe et al., 2001). Therefore, Part B of the QuIC instrument was used to assess participants’
beliefs about being informed about their study. The QuIC is written at an 8th grade reading level.
The interclass correlation coefficient (ICC) was .66 (Part A). It was noted that subjects with
lower scores had greater test–retest variability than those with higher scores. Part A of the QuIC
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instrument had a mean score of 76 and Part B summary scores averaged 87.2 and the interclass
coefficient was .77 during pilot testing of the instrument (Joffe, et al., 2001).
Informed Consent Form. The Flesch-Kincaid readability of the informed consent form
may impact participants’ ability to read and understand their consent and was collected as a
potential confounding variable.
Procedures
Human subjects protection. This research proposal was approved by the Institutional
Review Board (IRB) at the University of Wisconsin-Milwaukee where the Principal Investigator
was a student (Appendix A) and the IRB at the participating hospital (Appendix B).
Teach back intervention. The intervention for this study was the teach back process of
communication. Teach back has been defined as “asking patients to repeat in their own words
what they need to know or do, in a non-shaming way” (The Ethics Center, 2006, p. 2). Teach
back is a communication method used to enhance comprehension and retention of information,
and assess for understanding (Wilson, Mayeta-Peart, Parada-Webster, & Nordstrom, 2012).
During teach back, the patient or participant is asked to repeat back to the educator, in their own
words what they heard. This allows for assessment of understanding and the correction of any
misinformation.
The Cardiology Research Coordinators at the participating hospital are Registered
Nurses holding certifications from the Society of Clinical Research Association (SOCRA) or
from the Association of Research Professionals (ACRP). Passing the certification exam from
either of these national organizations allows the nurse to use the credential, Certified Clinical
Research Coordinator (CCRC). The certification demonstrates competence and expertise in
preparing or reviewing documents submitted to the Institutional Review Board (IRB), protocol
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review and study procedures, planning, maintaining source documents, preparing for study site
visits from a monitor, sponsor, or auditor, and obtaining informed consent. The Cardiology
Research Coordinators are responsible for obtaining informed consent for all clinical trials within
the department at the study site.
The curriculum for the teach back education was developed by the Student Principal
Investigator who has previously been educated in teach back. The Teach Back curriculum
included the purpose of the presentation, objectives, the Institute of Healthcare Improvement’s
(IHI) top patient safety measures, background on health literacy, a review of research describing
communication challenges in healthcare and its impact on patients, a review of research on
participant miss-understanding of their clinical trial, definition of teach back, examples of plain
language, goals of teach back, a short teach back video demonstration, examples of questions to
elicit teach back, and references.
The teach back education consisted of power point slides (Appendix G) provided to the
Cardiology Research Coordinators as a live class, including a video of a demonstration of teach
back. This educational presentation was approved for 1.0 contact hour of continuing nursing
education by the Northeast Multi-state Division Continuing Nursing Education, an accredited
approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Immediately after the educational session, the Cardiology Research Coordinators
completed a 10-question quiz covering the educational content (Appendix H). The quiz was
developed by the Student Principal Investigator and reviewed by a nursing faculty colleague for
content and formatting of questions. The nursing faculty colleague has several years of
experience as nursing faculty, holds a Master’s Degree in Nursing Education and is certified in
Nursing Education by the American Nurses Credentialing Center (ANCC). Interrater reliability
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was achieved by the coordinators attaining a passing score of 90% or better on the quiz therefore
establishing an inter-rater reliability of .90 or higher. If this score was not achieved, teach back
content would have been reiterated with more demonstrations, role playing and a question and
answer session until a minimal interrater reliability score of .90 was achieved. Inter-rater
reliability values of 75- 90% (.75-.90) are considered acceptable levels of agreement (Barrett,
2001; Stemler, 2004).
Data Collection
Informed Consent Form
A blank copy of the informed consent form (ICF) that each participant had signed for
their specific study was evaluated for reading level with the Flesch-Kincaid reading score.
Pre-intervention (Control Group)
Cardiac clinical trial participants, who signed informed consent and were currently
participating in one of the departments open cardiology clinical trials, were mailed a study
packet. The study packet contained a cover letter explaining the study (Appendix C), the
demographic data collection tool (Appendix D), the QuIC instrument (Appendix E) and a
stamped, addressed return envelope. As a strategy to potentially increase response rate, a
reminder postcard was mailed 2 weeks after the study packet was mailed (Appendix F) (Dillman,
1991). All data collected by the Student Principal Investigator (SPI) (a total of 18 surveys) were
kept in a locked file cabinet drawer in the SPI’s locked office. Participants were assigned a study
ID number consecutively beginning with 001. No Protected Health Information (PHI) was linked
to the assigned study ID number.
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Post Intervention (Experimental Group)
Fourteen cardiology clinical trial participants who signed consent after the teach back
intervention were enrolled into the post-intervention group. Four participants were mailed the
study packet. The study packet contained a cover letter explaining the study (Appendix C), the
demographic data collection tool (Appendix D), the QuIC instrument (Appendix E) and a
stamped, addressed return envelope. A reminder postcard was mailed two weeks later. Ten study
packets were hand-delivered to potential participants per the research coordinator’s request. A
total of 5 surveys were returned for a 36% response rate.
Data Analysis
Data Management
Scores on the QuIC were calculated by the SPI, per the authors’ instructions (Joffe et al.,
2001). Data were then entered into the Statistical Package for Social Sciences (SPSS) v. 21.
Returned surveys were reviewed by the student PI for completeness and missing data. Data were
periodically checked by the SPI throughout the data collection process to examine for any odd
findings or outliers.
Preliminary Analyses
Descriptive statistics (means and frequency distributions) were used for demographic
variables to describe the study sample. Descriptive statistics were used to describe the pre and
post-intervention groups’ responses on the QuIC. The analyses included number and percentage
of correct answers, and mean scores by domain.
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Primary Analyses
To answer the study’s primary research question, In research participants, will the use of
the teach back method of communication compared to standard language, improve objective
understanding of informed consent, an independent samples t-test was conducted. To answer the
study’s secondary research question, In research participants, is the relationship between
objective and subjective understanding different in the control group (standard communication)
compared to the experimental group (teach back communication) an independent samples t-test
was conducted.
Additional Analyses
A Chi square test was used to explore the relationships of the categorical variables of
education, income and history of research participation to the mean scores on the QuIC for the
pre and post intervention groups.
Limitations
There were a few limitations to this research that merit discussion. First, is the sampling
method. Ideally, randomization of participants would be preferred. Unfortunately, that is not
possible within the current infrastructure of the setting for this research study. As Conn et al.,
(2001) state, research studies conducted in real world settings often
must compromise one aspect of an experiment in order to gain control over a more important
source of variations within the study. Another limitation is that participants’ were asked to recall
the informed consent process. While the literature recognizes that recall, or memory and
comprehension or understanding are two distinct concepts, (Dunn & Jeste, 2001; Falagas,
Korbila, Giannopoulou, Kondilis, & Peppas, 2009) there is the potential for recall bias from the
participants. The third limitation is the lack of blinding for the research coordinators. The
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research coordinators were aware of the objectives of the study prior to the intervention and thus
introduces the potential for bias.
Chapter Summary
This chapter described the methods used to examine research participants’
understanding of informed consent. Specifically, to test whether or not using the teach back
method of communication improved research participants’ understanding of key elements of
informed consent when agreeing to participate in a cardiology clinical trial. Procedures
throughout the study have been described including the study’s limitations. The following
chapter will describe preliminary and primary analyses, and includes the third manuscript of the
pre-intervention group study results.
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CHAPTER 4 RESULTS
This chapter begins with a description of data cleaning procedures and preliminary
analyses for both the pre and post intervention groups. The primary analyses follows. The third
manuscript is included and focused on the results of the pre-intervention group only including
descriptive analyses. Finally a summary concludes the chapter.
Preliminary Analyses: Pre-intervention Group
Data Cleaning
All data were entered into the Statistical Package for Social Sciences (SPSS v. 22). When
conducting human subject research it is rare to have a complete dataset (Pallant, 2010). This is
true of this study where two pre-intervention surveys were returned with missing data. Missing
data were coded -.9, a unique code not corresponding to any numeric data on the survey. Missing
data were not used in computing summary statistics and the denominators were changed
appropriately (Smith, Budzeika, Edwards, Johnson, & Bearse, 1986). Two participants in the
pre-intervention group (11% of the sample) did not answer question A17 on the QuIC, a question
on the concept of payment for research-related injury. One of these participants (6% of the
sample) also did not answer question A 18. Question A18 seeks to identify if the participant
knows who to contact should they have any questions about their clinical trial. These omissions
of data are considered illegitimate missing data according to Osborne (2013). Illegitimate
missing data can occur when participants intentionally or unintentionally skip a survey question.
Given that two participants (11%) did not answer the same question, A17, may infer this data is
missing not at random (MNAR) and could potentially result in bias (Osborne, 2013). Mean
scores were calculated from only responses with valid values and denominators were changed
appropriately to accurately reflect the number of completed responses on the QuIC (Smith et al.,
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1986). When analyzing results for Part A of the QuIC, scores were calculated according to the
author’s instructions (Joffe et al., 2001).
Before beginning data analysis it is imperative to check for any inadvertent errors in the
data. Undetected errors can greatly affect the data analysis (Pallant, 2010). Data cleaning
procedures were completed in SPSS per recommendations found in Pallant (2010). This included
running frequencies for each of the answers on the QuIC. Both categorical variables and
continuous variables were checked for accuracy and no errors were found in the data.
Descriptive Analyses
The next step was descriptive analysis to check for assumptions. This was first done by
looking at sample distributions by running descriptive statistics on the pre-intervention group
(n = 18). Frequencies were assessed for all questions on the QuIC. For the categorical variables,
descriptive statistics were run and frequencies were examined. For continuous variables,
descriptive statistics were run including an examination of skewness and kurtosis. Skewness of a
sample describes the symmetry of the distribution whereas the kurtosis describes the peak of the
distribution. If both skewness and kurtosis were normally distributed a value of 0 for each would
be seen. A negative skewness indicates a clustering of scores at the high end, or right side of a
graph, with positive skewness indicating a clustering of scores at the left, or low end.
The general rule to follow is a skew of +2 to -2 range is considered normal distribution
(Garson, 2012). A positive kurtosis indicates the sample distribution to be peaked (Pallant,
2010). For this sample a skewness of -1.4 and a kurtosis of 1.25 were noted. A Kurtosis of +2 to 2 is also considered normal distribution (Garson, 2012). These results indicated there was a
normal distribution to the sample.
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Assessing normality of the sample was completed by comparing the mean and trimmed
mean scores. To obtain trimmed mean scores the top and bottom 5% of cases were removed and
a new mean value was calculated. This allowed for a comparison of the original mean value to
the new trimmed mean value to determine if there were any extreme scores influencing the
mean. When comparing scores for both Part A mean and trimmed mean the scores were 75.44
and 75.38 respectively. Scores this similar indicate there were no extreme scores in the sample
influencing the means (Pallant, 2010). The mean and trimmed mean scores for Part B were 88.72
and 89.61 respectively, again, indicating no extreme scores influencing the means. Additionally,
the Schapiro-Wilk’s W test was conducted to determine distribution. The Shapiro-Wilk’s W test
is recommended for small samples (Garson, 2012). The results were non-significant for the QuIC
Part A indicating a normal distribution but were significant for Part B scores indicating an
uneven distribution. Finally histograms and a Normal Q-Q Plot were evaluated in SPSS where
no outliers were observed.
Descriptive analyses including frequencies and percentage distributions were conducted
on questions on the QuIC instrument and are reported in Manuscript Three.
Preliminary Analyses: Post-intervention Group
Data Cleaning
All data were entered into the Statistical Package for Social Sciences (SPSS v. 22). When
analyzing results for Part A of the QuIC, scores were calculated according to the author’s
instructions (Joffe et al., 2001).
Before beginning data analysis it is imperative to check for any inadvertent errors in the
data. Undetected errors can greatly affect the data analysis (Pallant, 2010). Data cleaning
procedures were completed in SPSS per recommendations found in Pallant (2010). This included
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running frequencies for each of the answers on the QuIC. Both categorical variables and
continuous variables were checked for accuracy and no errors were found in the data.
Descriptive Analyses
The next step was descriptive analysis to check for assumptions. The same procedures for
preliminary analysis for the post intervention group (n = 5) were conducted as described above
for the pre-intervention group. For the categorical variables, descriptive statistics were run and
frequencies were examined. For continuous variables, descriptive statistics were run including an
examination of skewness and kurtosis. For this sample a skewness of -.901 and a kurtosis of 1.47
were noted. This sample was found to have a normal distribution.
To assess normality the mean and trimmed scores were examined. For Part A of the QuIC
were 68.43 and 68.56 respectively. For Part B of the QuIC the mean and trimmed mean scores
were 80.28 and 81.58 respectively. The Shapiro-Wilk’s W test indicated a normally distributed
sample. Finally histograms and a Normal Q-Q Plot were evaluated in SPSS where no outliers
were seen.
Pre-intervention Sample Demographics
The sample included 12 males (67%) and 6 females (33%). Ages ranged from 36-84
years with a mean age of 66.6 years (SD = 17.35). See Table 4 for other sample demographics.
The Flesch-Kincaid readability statistics for the cardiac clinical trial consent form signed by this
cohort included the following: number of pages = 15, number of words = 5115, average number
of words per sentence 19.1, and grade level 10.5.
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Results of QuIC Part A
The total scores on the QuIC Part A (objective understanding) ranged from 55.76 to
96.15 out of a possible 100 with a mean score of 75.44 (SD = 12.86). See Table 4 for QuIC
domains, concepts and percentage correct.
One area of misunderstanding was that of an explanation as to whether any compensation
and an explanation as to whether any medical treatments are available if injury occurs, and if so,
what they are and where to access further information. This concept is captured in Domain 11.
Fifty percent of respondents answered this question correctly while the remaining 50% were
either unsure or answered incorrectly. Here the mean score was 69.0 (SD = 35.93) with a range
of scores from 0-100.
Other difficulties in understanding the concepts within the informed consent were found
in Domain 4, (see Table 4), a description of the procedures to be followed. This domain includes
two statements on the QuIC. Here, only 7 out of 18 participants (39%) answered correctly
(scores ranged from 50-100 with a mean score of 78.0 (SD = 20.8). Further analyses and
discussion for the pre-intervention group are found within the manuscript later in this chapter.
Teach Back Intervention
Teach back education was presented by the Student Principal Investigator (SPI) to two
of the three Cardiac Clinical Research Coordinators (Appendix G). The education was held in
the private office of one of the coordinators. Immediately after the educational session, the
Cardiology Research Coordinators completed a 10-question quiz covering the educational
content (Appendix H). Interrater reliability was achieved by the coordinators attaining a passing
score of 90% or better on the quiz therefore establishing an inter-rater reliability of .90 or higher.
Inter-rater reliability values of 75- 90% (.75-.90) are considered acceptable levels of agreement
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(Barrett, 2001; Stemler, 2004). Although the two research coordinators were satisfied with the
education and felt it would improve participants’ understanding, one limitation was the inability
to observe whether or not teach back was actually used during the subsequent informed consent
process.
Intervention Implementation
Following the educational intervention 4 study packets were mailed followed by a
reminder postcard 2 weeks later. Ten study packets were hand delivered to participants for a total
of 14 study packets. Five surveys were returned (36% response rate).
Post Intervention Sample
The sample was 5 males (100%). Ages ranged from 67-88 years with a mean age of 75.8
(SD = 8.70) years. See Table 4 for other sample demographics. The informed consent documents
signed by the post intervention group included the following: pages = 13, words = 4179, average
number of words per sentence = 20.6 and grade level = 11.4.
Table 2. Post Intervention Sample Demographics
Variable

Sample % (n)

Annual Income
Less than $25,000
$25,001-$50,000
$50,001-$75,000
$75,001-$100,000
More than $100,000
Highest Educational Level

20% (1)
40% (2)
20% (1)
20% (1)
0% (0)

0-8 years
9-12 years
High School/GED
1-2 yrs. College
4 yrs. College

0% (0)
40% (2)
0% (0)
0% (0)
60% (3)
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Sample Demographics
An independent-samples t-test was conducted to compare the mean ages between the
pre and post-intervention groups. There was no significant difference in mean age for the pre
intervention group (M = 66.67, SD = 17.35) and post intervention group (M = 75.80, SD = 8.70; t
(13.76) = -1.61, p =.27). Cross-tabulations were performed to compare pre and post intervention
groups with history of research participation. A Chi-square test for independence indicated no
significant difference between pre and post intervention groups and history of research
participation, X2 (1, n = 23) = .24, p = .62. A Chi-square test for independence indicated no
significant difference between pre and post intervention groups and income, X2 (1, n = 23) = .96,
p =.91). A Chi-square test for independence indicated no significant difference between pre and
post intervention groups and level of education, X2 (1, n = 23) = .86, = p =.35).
Quality of Informed Consent
The mean score on Part A was 68.45 (SD = 5.71). See Figure 4 for all mean scores by
domain. One area of notable misunderstanding was found in Domain 11, the domain related to
compensation for research-related injury, where 40% (n = 2) of participants answered correctly,
while 60% (n = 3) were either unsure or answered incorrectly. The groups’ mean score was 60
(SD = 41.83).
Another problematic area came in Domain 4, procedures to be followed. This domain is
measured by two questions. For the first question 40% of participants answered correctly, 60%
unsure. For the second question, no one answered correctly, 60% were unsure and 40% answered
incorrectly. Here the mean score was 45.0 (SD = 11.18). For the post-intervention group, study
procedures included a telephone or office visit at approximately 90 days, 180 days, 356 days, and
450 days at which time participants’ medical status is evaluated. This concept was also
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problematic for the pre-intervention group. See Table 4 for all domains, concepts and
percentages of correct responses.
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Figure 5. Post Intervention Group Mean Scores by Domain
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Mean Score

Table 3. QuIC Domains, Concepts and Percentage Correct (n = 5)
DHHS
QuIC
Domain and Corresponding Concept of the Quality of Informed Consent
Element Domain

Questions
&
% Correct
A1 = 100%

1

Domain 1

A statement that the study involves research

1

Domain 2

An explanation of the purposes of the research

A2 = 80%
A5 = 80%

1

Domain 3

The expected duration of the subject’s participation

A3 =100%

1

Domain 4

A description of the procedures to be followed

A10 =40%
A11 = 0%

1

Domain 5

Identification of any procedures that are experimental

A4 =100%

2

Domain 6

A description of any reasonably foreseeable risks or discomforts to the
subject

A12 = 0%

3

Domain 7

A description of any benefits to the subject that may be expected from the
research

A9 = 0%
A13 =80%

3

Domain 8

A description of any benefits to others that may be expected from the
research

A14 =
100%

4

Domain 9

A disclosure of appropriate alternative procedures or courses of treatment,
if any, that might be advantageous to the subject

A16 =20%

5

Domain 10

6

Domain 11

A statement describing the extent, if any, to which confidentiality of
records identifying the subject will be maintained
For research involving more than minimal risk, an explanation as to
whether any compensation and/or any medical treatments are available if
injury occurs, and if so, what they consist of and where further information
may be obtained.

A15 =
100%
A17 = 0%

7

Domain 12

An explanation of whom to contact for answers to questions about the
research, research subjects’ rights and whom to contact in the event of a
research-related injury to the subject

A18 =
100%

8

Domain 13

A statement that participation is voluntary, refusal to participate will
involve loss of benefits to which the subject is otherwise entitled, and the
subject may discontinue participation at any time without penalty or loss of
benefits to which the subject is otherwise entitled

A19 =
100%
A20 =80%
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Table 4. Individual Mean Scores and Standard Deviations on
the QuIC Part A Compared to Mean Scores on Part B
Participant
Part A Mean and
Part B Mean and
Number
(Standard Deviation)
Standard Deviation
1
69.23 (43.49)
40.00 (24.81)
2
71.15 (37.98)
87.14 (16.84)
3
75.00 (35.36)
80.00 (28.28)
4
59.61 (42.74)
97.14 (7.26)
5
67.30 (42.55)
97.14 (7.26)
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Figure 6. Pre and Post Intervention Mean Scores by Domain.
An independent-samples t-test was conducted to compare the mean scores on Part B of
the QuIC between the pre and post-intervention groups. There was no significant difference in
scores for the pre intervention group (M = 88.72, SD = 12.0) and the post intervention group
(M = 80.28, SD = 23.65; t (21) = 1.11, p = .27). Based on previous research it is not surprising to
see higher scores on Part B than Part A. The post-intervention group results demonstrated the
same areas or concepts of misunderstanding as the pre-intervention group. See Figure 4 for mean
scores for both the pre and post-intervention groups. The results of this sample also demonstrated
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poor understanding of research-related injury compensation and procedures to follow, again, an
unexpected finding not found in the literature.
Primary Analyses
The primary research question to be answered by this study was “In research participants,
will the use of the teach back process of communication improve objective understanding of
informed consent?” To answer this question an independent samples t-test was conducted to
compare the mean scores on Part A (objective understanding) of the QuIC between the pre and
post-intervention groups. There was no significant difference in mean objective understanding
score between the pre intervention group (M = 75.44, SD = 12.85) and the post intervention
group (M = 68.43, SD = 5.74; t (21 = 1.17, p = .057).
The second research question in this study was, “In research participants, is the
relationship between objective and subjective understanding different in the control group
(standard communication) compared to the experimental group (teach back communication?)”
To answer this research question an independent samples t-test was conducted to compare the
differences between objective and subjective understanding in the pre-intervention group to the
post intervention groups. There was no significant difference on the mean difference between
objective and subjective understanding between the pre-intervention group (M = 13.31, SD =
13.9) and the post intervention group (M = 11.82, SD = 25.1; t (21) = .174, p = .85.
Additional Analyses
Another step in the analyses was to examine what if any impact participants’
educational level had on research comprehension. Cross-tabulations were conducted with highest
educational level obtained and concepts that were problematic for both groups by examining
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specific questions on the QuIC. Highest educational level obtained were categorized into less
than high school (n = 6) and high school or higher (n = 17).
Question A4 measures understanding of procedures that are experimental. Both groups
had a poor understanding of this concept. There was no significant association between
educational level and understanding of experimental procedures, X2 (2, n = 23) = 2.99, p = .22.
Cross-tabulations were conducted for the categorical variables of educational level with
questions related to procedures to follow (Domain 4). A Chi-square test for independence
indicated no significant association between highest educational level obtained and answers to
question A10, one question in Domain 4, procedures to follow, X2 (2, n = 23) = 3.03, p = .21.
The same non-significant association was found with the second question, A11 in Domain 4, X2
(2, n = 23) = 1.95, p = .37. Results for question A12, potential risks, also demonstrated no
significant association with highest educational level obtained and understanding of potential
risks, X2, (2, n = 23) = 2.25, p = .32.
An understanding of benefits to self, as opposed to benefits for future patients are
captured in Domain 7 by answering questions A9 and A13 on the QuIC. A Chi-square test of
independence demonstrated no significant association between highest educational level
obtained and benefits to self on question A9, X2 (2, n = 23) = 1.95, p = .37, nor was there an
association on question A13, X2 (2, n = 23) = 3.55, p = .16.
The same procedures were performed to examine an association with highest
educational level obtained and the answer on the QuIC that measures understanding of
compensation for research-related injury, A17. A Chi-square test for independence indicated no
significant association between highest educational level obtained and understanding of
compensation for research-related injury, X2 (2, n = 23) = 1.15, p = .56. While further statistical
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analyses is limited due to the small sample size, these results demonstrate that having a higher
education has no impact on understanding key concepts within the consent form and/or during
the consenting process thus making comprehension difficult for all. This may be useful for
investigators and research coordinators to understand as one should not assume that a more
highly educated participant has a higher likelihood of understanding.
The final covariate in this study was the reading level of the informed consent
document. This would have been a valuable covariate to analyze if there had been multiple
consent documents read by these participants, however, only two consent forms were used for all
participants. The Flesch-Kincaid reading level of the informed consent forms were 10.5 and 11.4
for pre and post intervention groups respectively both of which are greater than the
recommended eighth grade level.
Descriptive statistics and frequencies were run on the pre-intervention group only and
cultivated into a manuscript for the journal IRB: Ethics & Human Research. This journal was
chosen because it is a peer-reviewed journal whose primary focus is ethical and policy related
issues of human subjects’ research, including results of empirical studies. The manuscript will
focus on pre-intervention data analysis with a focus on findings from this study not seen in the
literature and discuss any progress made to date on improvements for participants’
understanding. In the manuscript the “sample” refers to this study’s pre-intervention group. The
manuscript will be formatted per the journal’s requirements prior to submission.
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Abstract
United States federal regulations requires investigators obtaining informed consent for
research provide potential participants with information in a language and reading level easily
understandable for them. Despite this, it is common for consent forms to be written at a graduate
level. Previous studies have concluded that research participants’ do not understand basic
concepts of their clinical trial such as randomization, risks and benefits.
Thirty-eight cardiac clinical trial participants were mailed the Quality of Informed
Consent survey and a demographic form following their agreement to participate in their trial.
Eighteen surveys were returned for a response rate of 47%. Results demonstrate a poor
understanding of what procedures needed to be followed in their clinical trial and potential
compensation should they sustain a research-related injury. This report describes unexpected
findings not reported in the literature to date, discusses any progress made on improvements for
participants’ understanding and suggestions for future research.

Key words: Clinical trials, compensation, participants’ understanding, research-related injury,
risks
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Introduction
United States federal regulations requires investigators obtaining informed consent for
research provide potential participants with information in a language and reading level easily
understandable for them (Code of Federal Regulations, 2012). Despite this, it is common for
consent forms to be written at a graduate level. There is a body of knowledge demonstrating that
research participants have significant misunderstandings about the potential benefits, risks and
experimental nature of their research study (Barrett, 2005; Flory & Emanuel, 2004; Hietanen,
Aro, Holli, Schreck, Peura, & Joensuu, 2007; Jefford et al., 2010; Joffe, Cook, Cleary, Clark, &
Weeks, 2001; Schwartz & Appelbaum, 2008). Seventy-five percent of the public reports they
have little or no knowledge of clinical research or the participation process (Getz, 2007). This
issue compounds the problem faced by investigators obtaining consent for research participation
where many of the concepts required by federal regulations may be foreign to most of the public.
Background
In 2003, the National Center for Education Statistics (NCES) surveyed the American
adult population to ascertain English language literacy skills. Results demonstrated that 75
million Americans (36%) have basic or below-basic health literacy (National Center for
Education Statistics, 2003). Currently, approximately forty seven percent of Americans,
roughly, 90 million, have difficulties understanding health information given to them by their
providers (Wilson, 2009). It has been documented that patients absorb and recall only about half
of what physicians have communicated to them (Schillinger et al., 2003). In addition,
approximately forty to eighty percent of medical information is forgotten almost immediately
with the greater the information being given proportional to the amount of information forgotten
(Kessels, 2003).
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The purpose of this study was to assess cardiology research participants’ objective and
subjective understanding of informed consent.
Methods
Research Design This study used a descriptive design.
Setting
This study drew its sample from a population of Cardiology clinical trial participants in a
large, tertiary, acute care hospital in New England. This 600 + bed hospital is the major referral
center for cardiology patients in the state where procedures include pacemaker implants,
coronary artery bypass surgery, balloon angioplasty, robotic mitral valve replacement, transcatheter aortic valve replacement and open heart surgery. At the organization where this study
was conducted, there are 3 Clinical Research Coordinators in the department of cardiology that
are responsible for the oversight and conduct of clinical research including obtaining informed
consent.
Sample
The study used a convenience sample of cardiology clinical trial participants. Inclusion
criteria included English speaking and writing and enrolled in a cardiac clinical trial. Exclusion
criteria included anyone under the age of 18 years, patients with a current diagnosis of dementia,
Alzheimer’s or who are otherwise cognitively impaired or diagnosed with a mental illness, or
participation in a research study where assent was given by a legal guardian or someone other
than the participant themselves.
Measurement
Quality of Informed Consent. The Quality of Informed Consent (QuIC) instrument
developed by Joffe et al. (2001) started with the basic elements of informed consent outlined in
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federal regulations (Code of Federal Regulations, 2012). These include elements such as the
voluntary nature of the research, the risks and benefits, the use of Protected Health Information,
the cost to the participant as well as other key points that are required to be in the consent form.
The overall purpose of the instrument was to evaluate participants’ understanding of their
clinical trial. Part A of the QuIC measures objective understanding, what participants’ actually
understand. Part B of the instrument measures subjective understanding which assesses what
participants believe they understand (Joffe et al. 2001). Some of the elements such as “potential
benefits” may actually be two different concepts i.e. benefits to self and benefits to future
patients. Therefore the questions on the survey are composed of 13 independent domains (Joffe
et al., 2001). (Table 4). The QuIC contains 20 questions in 13 domains in Part A answered on a
Likert scale from 1 (disagree), 2 (unsure) and 3 (agree). Each correct answer in Part A is given a
score of 100 points, an “Unsure” response is given a score of 50 points and incorrect answers are
given 0 points. Unanswered questions are not scored.
Part B of the instrument contains fourteen questions answered on a Likert scale from 1 (I
didn’t understand this at all) to 5 (I understood this very well). Part B of the QuIC is scored by
taking the average responses to each of the fourteen questions and scaled from 0-100 (summary
score = raw average -1 x 25). This allows for equal weighting among the domains in the
instrument. The QuIC is written at 8th grade reading level. The interclass correlation coefficient
(ICC) was .66. It was noted that subjects with lower scores had greater test–retest variability than
those with higher scores. Part A of the QuIC instrument had a mean score of 76 and Part B
summary scores averaged 87.2 and the interclass coefficient was .77 during pilot testing of the
instrument (Joffe et al., 2001). Permission to use the QuIC was obtained from the author.
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Procedures
This study received approval from the Institutional Review Board (IRB) at the university
where the primary author is a student and the participating hospital. A study packet containing a
cover letter, demographic information sheet and the Quality of Informed Consent (QuIC) survey
were mailed to a convenience sample of 38 cardiac clinical trial participants. Two weeks
following the mailed surveys a reminder postcard was mailed to the same participants to increase
the response rate (Dillman, 1991). A total of 18 surveys were returned (47% response rate). All
data were entered into the Statistical Package for the Social Sciences (SPSS) v. 22.
Results
Sample Demographics
The sample included 12 males (67%) and 6 females (33%). Ages ranged from 36-84
years with a mean age of 66.6 years (SD = 17.35). See Table 4 for other sample demographics.
The Flesch-Kincaid readability statistics for the cardiac clinical trial consent form signed by this
cohort included the following: number of pages = 15, number of words = 5115, average number
of words per sentence 19.1, and grade level 10.5.
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Table 5. Sample Demographics
Variable
Sample % (n)
Annual Income
Less than $25,000
$25,001-$50,000
$50,001-$75,000
$75,001-$100,000
More than $100,001
Highest Educational Level

12% (2)
35% (6)
35% (6)
12% (2)
6% (1)

0-8 years
9-12yrs
High School/GED
1-2 yrs. College
4 yrs. College

11% (2)
17% (3)
22% (4)
17% (3)
33% (6)

Results of QuIC Part A
The total scores on the QuIC Part A (objective understanding) ranged from 55.76 to
96.15 out of a possible 100 with a mean score of 75.44 (SD = 12.86). See Table 4 for QuIC
domains, concepts and percentage correct.
One area of misunderstanding was that of an explanation as to whether any compensation
and an explanation as to whether any medical treatments are available if injury occurs, and if so,
what they are and where to access further information. This concept is captured in Domain 11.
Fifty percent of respondents answered this question correctly while the remaining 50% were
either unsure or answered incorrectly. Here the mean score was 69.0 (SD = 35.93) with a range
of scores from 0-100.
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Table 6. QuIC Domains, Concepts and Percentage Correct (n = 18)
DHHS
QuIC
Domain and Corresponding Concept of the Quality of Informed
Element Domain
Consent
1
Domain 1
A statement that the study involves research

Questions &
% Correct
A1 =100%

1

Domain 2

An explanation of the purposes of the research

A2 =100%
A5 = 100%

1

Domain 3

The expected duration of the subject’s participation

A3 = 83%

1

Domain 4

A description of the procedures to be followed

A10 =56%
A11 = 78%

1

Domain 5

Identification of any procedures that are experimental

A4 = 6%

2

Domain 6

A description of any foreseeable risks or to the subject

A12 = 22%

3

Domain 7

A description of any benefits to the subject that may reasonably be
expected from the research

A9 = 22%
A13 = 89%

3

Domain 8

A description of any benefits to others that may reasonably be
expected from the research

A14 =100%

4

Domain 9

A disclosure of appropriate alternative procedures or courses of
treatment, if any, that might be advantageous to the subject

A16 = 72%

Domain 10

A statement describing the extent to which confidentiality of
records identifying the subject will be maintained

A15 = 78%

6

Domain 11

An explanation as to whether any compensation and/or medical
treatments are available if injury occurs, and if so, what they
consist of and where further information may be obtained.

A17 = 50%

7

Domain 12

An explanation of whom to contact for answers to questions about
the research, research subjects’ rights and whom to contact in the
event of a research-related injury to the subject

A18 = 76%

8

Domain 13

A statement that participation is voluntary, refusal to participate
will involve no loss of benefits to which the subject is otherwise
entitled, and the subject may discontinue participation at any time
without penalty or loss of benefits to which the subject is
otherwise entitled

A19 = 100%
A20 = 41%

5

Other difficulties in understanding the concepts within the informed consent were found
in Domain 4, (see Table 4), a description of the procedures to be followed. This domain includes
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two statements on the QuIC. Here, only 7 out of 18 participants (39%) answered correctly
(scores ranged from 50-100 with a mean score of 78.0 (SD = 20.8). All participants in this
sample were enrolled in the same randomized clinical trial. For their study this cohort of
participants was randomized to receive or not receive a study envelope of antibiotic during
surgery for placement of a Cardiovascular Implantable Electronic Device (CIED). Study
procedures included physician visit on the day of surgery and day of hospital discharge.
Additional visits were required at 6 and 12 months post-surgery for the physician to monitor and
download data from the device and participants to complete a health questionnaire. No other
clinical trial procedures were required from the participants.
All participants scored 100 on Domains 1, 2 and 8 answering all questions related to
these domains correctly. These domains cover the concepts of research, purpose and potential
benefit to others (future patients). See Figure 4 for Part A mean scores for all 13 domains.
Part B scores ranged from 61.42 to 100 with a mean score of 88.73 (SD = 12.0). Only
two respondents (11%) scored lower on Part B than their mean score on Part A. Table 4 shows
the mean scores of Part A and Part B for all 18 respondents. Research has demonstrated that
participants believe themselves to be informed, have asserted the information provided to them
as easy to understand, but have demonstrated poor understanding (Hietanen et al., 2007).
Therefore, higher mean scores on Part B of the QuIC, when compared to Part A were not
unexpected. See Table 4 for a comparison of Part A and Part B mean scores.
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Figure 7. Mean Scores by Domain

Table 7. Individual Mean Scores and Standard Deviations on
the QuIC Part A and Part B
Participant
Part A Mean and
Part B Mean and
Number
(Standard Deviation)
Standard Deviation
1
96.15(13.87)
100.00(00.00)
2
57.69(49.35)
75.71(32.51)
3
79.16(38.19)
85.71(26.52)
4
92.30(18.78)
84.28(13.99)
5
69.23(39.73)
94.28(21.38)
6
80.76(34.09)
97.14(10.69)
7
55.76(37.02)
61.42(37.18)
8
63.46(36.25)
95.71(8.52)
9
65.38(36.14)
82.85(17.54)
10
76.92(31.39)
61.42(37.18)
11
84.61(29.82)
85.71(12.22)
12
65.38(41.51)
97.14(10.69)
13
75.00(38.19)
98.57(5.35)
14
75.00(20.50)
92.85(12.67)
15
65.38(42.74)
97.14(7.26)
16
92.30(18.78)
95.71(8.52)
17
96.15(13.87)
100.00(0.0)
18
67.30(37.34)
91.42(12.92)
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Discussion
Interestingly, one concept poorly understood by participants was options for them
should they sustain a research-related injury including who to call and whether or not they would
be compensated. This domain is measured by the following question, “The consent form I signed
describes who will pay for treatment if I am injured or become ill as a result of participation in
this clinical trial.” Fifty percent of participants were either unsure or did not know the correct
answer to this question. This was an unexpected finding and not reported in the literature.
What may be clear language in an informed consent document to a healthcare
professional is not always clear to a lay person. While consent forms may clearly state that
research-related injury will not be paid for by the study’s sponsor, it does not tell potential
participants that it is against United States (U.S.) federal regulations to pay for treatment of
research injuries. In fact, no agency within the U.S. federal health system has a formal
compensation policy for research injuries (Hochauser, 2004). Although medical care for
research-related injuries is mandatory, institutions are not required to provide compensation.
Adding to the problem is the difficulties in determining if a medical illness or injury are related
to the research, particularly if they occur several months later or if the patient has other illnesses
and/or co-morbidities (Steinbrook, 2006).
There is much debate on whether compensation to participants for a research-related
injury should be mandated or not. On one side there is the argument that sponsors and
institutions are ethically obligated to provide compensation for a research-related injury. The
other side of the argument is that compensation should not be provided because participants
understand the potential risks of their study when enrolling and signing informed consent
(Steinbrook, 2006). The results of this study would dispute this as participants’ demonstrated a
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lack of understanding of potential risks. This finding is also supported by previous studies. This
debate continues today, but does beg the question of participants’ understanding of risks and any
compensation to which they may be entitled. This also raises the ethical issues for patients
participating in clinical trials who do not have insurance and would therefore have no medical
coverage should they sustain an illness or injury as a direct result of their research participation.
If an un-insured research participant were to sustain an injury as a direct result of the clinical trial
participation, the financial ramifications may be numerous and therefore pose an unduly fair
burden to the participant.
The difficulty in understanding of procedures to be followed is cause for concern as
only 39% of the sample understood this. The misunderstanding of this concept is also not
described in the literature. One might wonder if participants’ clearly understood what procedures
they needed to follow in their clinical trial, might they still consent to participate. Additionally, if
trial-specific procedures are not clearly understood and followed by participants accuracy of trial
data may be jeopardized and/or protocol deviations may occur. For this cohort their clinical trial
procedures included physician office visits and the completion of a health questionnaire. If
participants missed any office appointment and/or the completion of the health questionnaire
they received a phone call from the research coordinator in order to remain compliant with the
protocol and collect the required data. For other clinical trials that may have more complex
procedures to be followed such as certain dosing of medications or time-specific laboratory
draws a lack of understanding of specific procedures to follow is very concerning.
Participants continue to fail to understand the critical differences between standard care
and experimental procedures (Brody, Dalen, Annett, Scherer, & Turner, 2011). This was evident
in the current study where 94% of participants were either unsure or did not understand this
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concept. The domains covering procedures that are experimental and risks to subjects were also
poorly understood and not surprising. Underestimating risks is a concept termed “therapeutic
misestimation.” In a study by Pentz et al. (2012) as many as 94% of the study sample of
Oncology clinical trial enrollees misestimated risk and benefit when asked. Most of the
misestimations were overestimations of potential benefit to themselves. When participants were
asked their motivation for enrolling into the clinical trial, 76% of patients had direct medical
benefit as at least one of several reasons for entering the trial (Pentz et al., 2012). Some
investigators have argued that patients who participate in research and understand their clinical
trial is not designed for their personal benefit, may still express high expectations of therapeutic
benefit but may not be suffering from therapeutic misconception, rather therapeutic optimism
(Horng & Grady, 2003; Sulmasey, Astrow, He, Seils, Meropol, Micco, & Weinfurt, 2010).
Based upon the results of this study it is especially important for clinicians and research
coordinators obtaining consent for clinical trial participation to focus on areas that may be
particularly problematic for participants to understand, especially the concepts of procedures to
follow and compensation for injury. It is recommended that members of the research team, other
than the physician treating the patient obtain consent to avoid further confusion between standard
and experimental care. Informed consent is an ongoing process and assessment of participant
understanding should not end once the informed consent document is signed. Additionally some
standardized method for evaluating participants’ understanding needs to be implemented in order
to clarify any misconceptions. Currently, there is no standardized process in place. Perhaps this
will occur only if regulations mandate it.
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Limitations
There are a few limitations to this research that need to be acknowledged. The first
limitation is the small sample size. The second limitation is that participants’ were asked to recall
the informed consent process in order to answer the questions on the QuIC. The concept of recall
refers to a function of memory which is different from that of understanding (Dunn & Jeste,
2001; Falagas, Korbila, Giannopoulou, Kondilis, & Peppas, 2009). Therefore, there is the
potential for recall bias from the participants. Lastly, two surveys had data missing not at
random. Interestingly the missing question on both surveys was the question regarding
compensation for injury. Data missing not at random may result in bias.
Conclusion
This study adds to the current body of knowledge by uncovering two unexpected
findings of poor understanding of compensation for a research-related injury and clinical trial
procedures to be followed. As early as 2003, the Institute of Medicine (IOM) recommended
institutions conducting research compensate research participants who are injured as a direct
result of participating in research, regardless of fault (Institute of Medicine, 2003). One argument
regulatory bodies and bioethics committees have taken regarding compensation is the lack of
quantifiable data on the number, severity, type and costs of research-related injuries (Federman,
Hanna & Rodriguez, 2003; Henry, 2013; Steinbrook, 2006). The issue of whether or not to
compensate participants should they become injured as a direct result of their clinical trial
participation remains unresolved.
If participants continue to view themselves as informed, as prior research has suggested,
a mixed-methods study employing both the QuIC questionnaire and targeted questions via
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individual interviews to glean understanding, clarify misunderstandings and gather both
inductive and deductive data may yield some interesting results.
Based upon the results of this study and other studies, research participants’
misunderstanding of key concepts related to their clinical trial continues to be problematic. It is
suggested that future research be conducted to test the teach back method with this cohort, enroll
a larger sample and address the limitations in this and other studies. Additionally, more studies
are needed to capture data on research-related injuries. The volume, extent and costs of those
injuries need to be quantified in order to obtain data to guide policy development.
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Chapter Summary
The results of this study indicated there was no statistically significant difference in
objective understanding between the pre and post intervention groups. Additionally, there was no
significant differences between objective and subjective understanding in the two groups.
Therefore the null hypotheses cannot be rejected. The reader is should interpret these findings
with caution due to the small sample size.
Two important areas for informed consent mandated by United States regulations are
what procedures to follow and compensation for a research-related injury. The results of this
study demonstrated poor understanding of these two concepts not reported in the literature and
therefore added to the current body of knowledge on this topic. Misunderstanding of other
concepts such as potential risks, benefits and a distinction between experimental care and
standard care are also evident in this study and support the literature. Additionally, having a
higher education did not show an association with better understanding of other key concepts
such as risks, benefits to self, experimental procedures, procedures to follow and research-related
injury compensation.
The following chapter includes a description of major findings from the study, a
discussion of study limitations and implications for nursing, policy and research.
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CHAPTER 5 SYNTHESIS
This chapter includes a discussion of the major findings from the study, study limitations
and implications for nursing, policy and research.
Major Findings from the Study
There was no statistically significant improvement in objective understanding of
informed consent for the post intervention group. It was hypothesized that the teach back method
of communication would decrease the noise as described in the theoretical framework supporting
this study (Shannon & Weaver, 1948). This would be achieved by the research coordinator
(sender) simplifying the language from medical and legal terminology into lay language during
the consenting process where the participant (receiver) would teach back the content during the
feedback loop, allowing for clarification of any misunderstandings.
Despite the challenges this study encountered the data analysis yielded interesting
findings. Two specific findings from this study were unexpected as they are not reported in the
literature. One unexpected finding was participants’ lack of understanding on whether or not they
are entitled to compensation for a research-related injury. This was evident in both the pre and
post-intervention groups. Understanding of this concept is captured in Domain 11. Additionally,
participants did not understand clinical trial procedures to follow per responses found in Domain
4. The lack of understanding of these two concepts was evident in both the pre and postintervention groups.
Research-related injury and possible compensation are one of the elements required to be
disclosed during the informed consent process and included in the informed consent document.
Federal regulatory bodies and bioethics committees have debated the ethics of providing
research-related injury compensation to participants of clinical trials. Some argue that
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participants freely volunteer to enroll into clinical trials fully aware of any potential risks.
Compounding the problem is the difficulty in determining if an injury or illness has occurred as a
direct result of the clinical trial due to participants overall health, age, and other co-morbidities
they may have. This makes an accurate assessment of causality challenging. Others disagree
stating that providing financial compensation for a research-related injury would be the ethical
thing to do. It is not safe to assume that all participants are covered through Medicare, Medicaid
or private insurance and for those trial participants who do become injured as a result of their
research participation and have no health care coverage would incur a significant financial
burden. The lack of understanding of this concept is not reported in the literature and was an
unexpected finding in this study.
For the pre-intervention group, clinical trial procedures included physician visits both in
and out-patient and the periodic completion of a health questionnaire at specifically timed
intervals. No other procedures were required from this group. For the post-intervention group,
study procedures included a telephone or office visit at approximately 90 days, 180 days, 356
days, and 450 days at which time participants’ medical status is evaluated.
While these procedures seem straightforward, the overall mental and physical health of
participants and whether or not that had any bearing on results is unknown. A poor
understanding of clinical trial procedures could potentially lead to poor quality data or protocol
deviations if not strictly followed. These two finding add to the body of science on what is
currently known about research participants’ understanding of informed consent and merits
further exploration.
Research participants’ poor understanding of which procedures are standard care versus
experimental, benefits to self and potential risks of the study were also apparent in this study for
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both pre and post-intervention groups. A lack of understanding of these 3 concepts has been
identified for more than 20 years.
Finally, these results demonstrate that having a higher education had no impact on
understanding key concepts within the consent form and/or during the consenting process thus
making comprehension difficult for all. This may be useful for investigators and research
coordinators to understand as one should not assume that a more highly educated participant has
a higher likelihood of understanding.
Research has also demonstrated the longer the consent form the increase in difficulties
with comprehension (Mann, 1994). The Flesch-Kincaid statistics of the informed consent
document for the pre-intervention group was a reading level of 10.5, 15 pages in length and
contained 5115 words. For the post intervention group, the informed consent document had a
reading grade level of 11.4, was 13 pages long and contained 4179 words. This may or may not
have had any bearing on the participants’ level of understanding but is clearly over the desired
eighth grade reading level.
Many studies have attempted to test interventions to improve informed consent
understanding but have mixed results as reported in Chapter 2. Despite the plethora of research
describing clinical trial participants’ poor understanding of key concepts of their study, and many
various interventions attempting to make improvements in understanding the issue persists.
Study Challenges
This study was fraught with many site-specific challenges which ultimately lead to a
change in the research design and data analysis. One of the challenges for this study was the
student Principle Investigator not being an employee where the study took place. Not being
embedded within the organization lead to a heightened sense of mistrust from one coordinator.
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Despite best efforts to clarify confusion as to the purpose of the study, there was a general sense
from the coordinators that evaluating participants’ understanding may be a reflection on their
capabilities to provide informed consent and therefore they were somewhat reluctant to offer
their support. The research coordinators also declined to informed consent observations which, if
completed would have added internal validity to the study. The director of cardiology was a key
stakeholder and instrumental in the success of the study, however, communication with was
challenging and his time very limited. Despite his being supportive of this study, his managerial
style was very much hands-off allowing the coordinators to control and direct the flow of the
study. Despite the many barriers the study was completed. Interesting the data yielded some
unexpected results, not widely reported in the literature.
Limitations
The major limitation to this study was the sample size. Study challenges prevented data
collection on the desired sample size determined a priori to the conduct of this study, despite
many strategies at attempting to increase participation. Statistical analyses were conducted as
planned to answer the primary research questions however results may reflect that of a Type II
error. The small sample size increases the likelihood of concluding that the experimental
intervention does not differ from the control, therefore power of the study may be inadequate
(Guyatt, Jaeschke, Heddle, Cook, Shannon, & Walter, 1995). “The likelihood of missing an
important difference (and making a Type II error) decreases as the sample gets larger” (Guyatt et
al., 1995, p. 27).
Limitations to this study also include the quasi-experimental design. Ideally,
randomization of the sample would have added scientific rigor to the study but was impractical
given the clinical setting of the study. The ability to explain the effect of interventions or changes
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that may have occurred simultaneous to the study intervention is limited with pre-post study
designs. Bias can arise when nurses know that their performance and the impact of a practice
change are being monitored for research purposes. It may be possible that the research
coordinators’ behavior changed when consenting participants as they were not blinded to the
study’s aim and intervention. Another limitation is the potential for recall bias from participants.
The final limitation was the inability to observe the consenting process. Observations of the
communication methods used by the coordinators, that of standard communication or teach back
would have added internal validity to the study.
Implications for Nursing
Given the relocation of clinical trials from academic medical centers to community
settings, nurses need to be cognizant of the functions related to clinical trials. Whatever the
clinical setting, nurses are increasingly likely to confront patients who are participating in a
clinical trial (Parreco, Ness, Galassi, & O’Mara, 2012). Therefore, nurses working in a variety of
settings need to be knowledgeable about the regulatory requirements of informed consent and be
able to answer patients’ questions, even broadly about their clinical trial. To increase clinical
nurses’ awareness of this issue, in 2011, the journal, American Nurse Today published a fourpart series discussing what clinical nurses need to know when taking care of patients enrolled in
a clinical trial.
As much as 80% of medical errors are attributed to miscommunication among
caregivers (American Nurses Association, 2012). This is echoed by The Joint Commission who
states that poor communication was the root cause 65-70% of the time when analyzing more than
3000 sentinel events from 1995-2005 (Adamski, 2007). Nurses providing education and
information to patients need to be aware of the patients’ health literacy, functional ability and
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capacity to understand. It is not uncommon to ask patients if they have any questions which does
not provide for an accurate assessment of understanding. Teach back method of communication
assesses patient understanding and allows for corrections of information as needed. Teach back
communication takes training and practice, not universally available to many nurses today. The
Institute of Medicine reports that “if health professionals were able to take the time to ask their
patients to explain exactly what they understand about their diagnosis, instructions and bottle
labels, the caregivers would find many gaps in knowledge, difficulties in understanding and
misinterpretations” (Institute of Medicine, 2004, P. XI).
One provision of the Affordable Care Act is the implementation of shared decisionmaking. While this may be a strong recommendation few policies are available to guide practical
application (Maughn et al., 2016). It has been suggested that the practical application of shared
decision making may include the use of patient decision aids such as written materials, videos,
or interactive electronic aids, all of which are intended to inform patients and their families about
treatment options (Lee & Emanuel, 2013). Nurses, as frontline clinicians are well positioned to
embrace shared-decision making as they will play a pivotal role in patient education and with
training in communication techniques designed to improve understanding, could take an early
lead on this initiative.
Implications for Policy
One of the major ethical principles guiding research conduct with human subjects as
outlined in the Belmont Report is the principle of respect which honors individuals’ right to
choice (National Commission for Protection of Human Subjects of Biomedical and Behavioral
Research, 1979). Working within this principle, investigators are required to provide a consent
process to potential research participants with sufficient knowledge and understanding of
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research for informed decision making (Whitney, 2001). Despite this, it is common practice for
physicians, investigators, research coordinators and others obtaining informed consent to not
verify participants’ understanding. The Office of Human Research Protection (OHRP) offers
little guidance on how to obtain consent, but rather is instructive on regulatory requirements
only.
The Code of Federal Regulations (2017) has recently been revised to improve
participants’ ease with decision-making and includes alterations to the requirements for informed
consent relating to the content, organization, and presentation of information included in the
consent form. These changes occurred as a result of studies claiming consent forms have
significantly lengthened, become more complex and appear to be designed to protect institutions
rather than to provide potential research participants with the most important information needed
to make an informed decision (Beardsley et al., 2007; Code of Federal Regulations, 2017;
Levine, 1991). Part of the organizational changes to the consent form mandate the eight required
elements be disclosed first and all other information be added as appendices. It is the hope that
this “core” of the consent form will provide clear concise information to potential participants in
one location rather than having the required elements buried in other medical and legal verbiage
throughout the document (Code of Federal Regulations, 2017). These new regulations will
become effective in 2018 and therefore it remains to be seen whether these will lead to
improvements in participants’ understanding. Given the plethora of research demonstrating poor
comprehension it would behoove researchers to apply the new recommendations now rather than
wait until they become legally required.
The findings from this study warrant dissemination among Institutional Review Boards
(IRBs) across the private and public sectors. IRBs are charged with the protection of human
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subjects and are therefore key players in mandating informed consent documents be written and
formatted in an easily understandable style and have the authority to request such changes prior
to approval. IRBs and research compliance programs across healthcare and academic settings
need to develop policies and protocols as guidance for investigators including templates using
plain language. Research compliance programs need to be established that will develop quality
improvement initiatives on informed consent such as follow-up inquiries with participants
regarding their comprehension of the eight required elements.
Additionally, the Society of Clinical Research Association (SOCRA) and the Association
of Research Professionals (ACRP), two national organizations certifying registered nurses as
research professionals do not have a policy or regulatory requirement for competency in
obtaining informed consent, nor verifying participants’ understanding.
The impetus for this research study was born from a descriptive study previously
conducted by the student Principal Investigator examining participants’ understanding of
research consent (Palmer & Trott, 2013). The descriptive study was conducted as a quality
improvement initiative as part of the organization’s application to achieve accreditation from the
Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). It
was, at that time, a plan to develop a comprehensive program for the organization’s research
coordinators and other investigators to demonstrate competency in obtaining consent for research
participation. This program would include a policy for developing competency in consenting and
incorporate teach back communication as a method to assess for understanding. More policies
from organizations’ Institutional Review Boards and the national level could mandate some
method for investigators to verify potential participants’ understanding.
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Medical care is designed to provide individual patients with the best treatments possible
for their particular illness. Research, by contrast, has as its primary goal the creation of
generalizable knowledge that may be of benefit to future patients. These different goals result in
different relationships. Federal regulations require researchers to disclose potential harms of the
research study, but researchers are not required to advise potential participants as to whether
participation is in their best interests (Pike, 2012). “Some scholars argue that being a patient in a
clinical care setting and a subject in a research study are so different that anything that would
promote in subjects the view that they are in clinician-patient relationships is exploitative and
deceptive” (Easter, Henderson, Davis, Churchill & King, 2006, p. 695). One solution to decrease
confusion patients may have between standard care and experimental care would be to have a
member of the research team other than the treating physician obtain research consent. Much of
the literature suggests this practice but it is not mandated by federal regulations.
To address the issue of therapeutic misconception the National Institutes of Health (NIH)
created a forum to examine the issue and make recommendations (Henderson et al., 2007). A
panel of experts was formed and identified 5 major areas of understanding determined necessary
for an adequate comprehension of research in order for potential participants to distinguish
health research from health care. These domains included a clear understanding that the scientific
purpose of a study is designed to produce generalizable knowledge, research participation may
involve study procedures intended only to generate scientific knowledge not necessary for
patient care, the interventions studied in clinical research are based on less certainty about risks
and benefits to a population than when a doctor prescribes standard treatments, treatments are
based on a strict adherence to a protocol with defined doses and scheduling and clinicians as
investigators presents physicians in dual roles that may confound the distinction between
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treatment and research. Despite these noble efforts, little has actually changed in the practice of
enrolling participants into clinical trials.
Implications for Research
Informed Consent
Based on the unexpected results from this study, further research is needed to explore
participants’ understanding of compensation for research-related injury. More research into
participants’ understanding of this concept may determine whether this was problematic for this
particular cohort or in fact, a more global issue. No studies to date have taken an inductive
approach to glean participants’ understanding and therefore this method may provide valuable
insights into the issue.
Additionally, as some regulatory bodies have contended, studies are needed to quantify
the volume of research-related injuries, the nature, extent and costs of those injuries to guide
policy development. “Despite the requirement to report serious adverse events to sponsors,
Institutional Review Boards and regulatory authorities, there are few systems in place to quantify
the severity, frequency and types of injuries and the associated costs of managing medical care or
rehabilitation in any country” (Kang, 2012, p.78). Future policies cannot be developed to protect
clinical trial participants in the event of a research-related injury until there is the science to
inform clinical practice.
Additionally, more studies are needed to glean rigorous data on clinical trial participants’
understanding of procedures to follow. A misunderstanding of this concept was evident in this
study yet is not widely reported in the literature. More studies are needed to support or refute this
finding. If other research supports this finding and it becomes apparent this is a problematic area
for clinical trial participants, strategies will need to be developed and tested to improve
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participant understanding of this concept. Without a clear understanding of clinical trial
procedures autonomous and informed voluntary participation is jeopardized as well as clinical
trial data and protocol adherence.
Previous studies have agreed the concept of potential benefit associated with research
participation is difficult for participants to understand (Joffe et al., 2001). Benefit for self, despite
clear explanations from those conducting the consent is a concept originally described by
Applebaum, Roth, Lidz, Benson, & Winslade (1987) as “therapeutic misconception” and is
widely reported in the literature. “Unfortunately, therapeutic misconception has been used
loosely to refer to any number of misunderstandings that subjects may have in the research
context. This imprecise use of the term can itself cloud our assessment of when informed consent
is compromised” (Horng & Grady, 2003, p.11). Jansen, Applebaum, Klein, Weinstein, Cook,
Fogel, & Sulmasy (2011) suggests this may be a common occurrence, particularly in Oncology
clinical trials. Exactly why participants may overestimate benefits and/or underestimate risks has
been the topic of much discussion, yet remains unclear. The concept of unrealistic optimism
needs further exploration.
To date, the vast majority of studies examining research participants’ understanding have
taken a deductive approach. Very few studies using inductive methods to glean participants’
understanding are reported. Qualitative approaches to explore this concept may provide
interesting results and add to the current body of science on this important topic.
This study could also build a comprehensive research program examining the issue of
informed consent for surgery or other medical procedures. Informed consent for surgery, medical
procedures not deemed research or in the construct of informed, autonomous shared decisionmaking are still lacking in the literature.
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Teach Back
Teach back has demonstrated enhanced patient understanding leading to improved patient
outcomes in a number of studies (Kornburger et al., 2013; Negarandeh et al., 2012, Peter,
Robinson, Jordan, Lawrence, Casey, & Salas-Lopez, 2015). However, to date, only one study
has empirically tested the teach back method in clinical trial participants (Kripalani et al., 2008).
It is recommended that study be replicated with a larger sample of clinical trial participants.
Further research is also recommended in other cohorts of clinical trial particiants, such as
oncology where difficult and lengthy informed consent documents are common.
Communication
Patients have increased access to the internet and hospitals’ public reporting of core
quality measures thus are more educated, informed consumers. Poor communication is the
primary reason for filing a medical malpractice suit in more than 80% of cases (Avery, 1985).
Weiss, Reed, & Kligman (1995) demonstrated that patients have difficulties understanding
instructions given to them by their physicians. Additionally, healthcare practitioners overestimate
their own effectiveness in communication and underestimate patients’ need for information
(Schillinger, et al., 2003). Providers continue to use medical terminology, communicate too
much to the patient causing information overload and do not routinely assess patient
understanding (Kripalani & Weiss, 2006). Strategies to improve communication may diminish
the number of litigious cases. However, to communicate effectively, nurses and other healthcare
practitioners need to familiarize themselves with the issues involved in the communication
process. Once there is an awareness of these issues plans can be made to analyze situations, solve
problems, and make process improvements. The use of the Shannon Weaver theory will allow
for this identification and analysis. According to Walker and Avant (2010) where there are
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untested theoretical concepts it is prudent to test those relationships which will add to the body of
knowledge. This communication theory would be an excellent framework for research regarding
miscommunication during patient hand-offs as seen in the literature where shift report between
nurses is often taking place in a busy, loud and distracting nurse’s station.
Chapter and Dissertation Summary
Empirical studies assessing research participants’ understanding of informed consent
have been seen in the literature for a number of years. This study tested the teach back
communication method as an intervention to improve research participants’ understanding of
informed consent and was supported by the Shannon Weaver communication theory. Many
study site-specific challenges limited access to clinical trial participants resulting in a small
sample size. Despite this the analyses demonstrated that participants in both the pre and post
intervention groups had a poor understanding of compensation for research-related injury and
clinical trial procedures to follow. These findings have not been previously reported in the
literature. Targeted interventions need further assessment to develop appropriate methods to
improve understandings and tackle the ethical issues of compensation for research-related
injuries.
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APPENDIX C
Cover Letter

To Whom It May Concern:
I understand you are currently enrolled in a Cardiology clinical trial (a research study).
I am conducting a research study to evaluate the informed consent process and your
understanding of the information presented to you. By completing the information on the
demographic form and the survey questions you are consenting to participate in this study.
There is no benefit to you to complete this survey, but I hope the information I receive from this
study will benefit future research patients. There is no risk to you to complete the survey. Do not
write your name on the survey. All completed surveys will be anonymous.
This is completely voluntary. If you do not wish to fill out the survey, you do not have to. The
care you are currently receiving from your physician and the research study you are participating
in will not be jeopardized by not completing this survey.
Some of the questions may not apply to your clinical trial. Please answer the questions to the best
of your ability or simply write NA (not applicable) beside the answer. I hope that you and other
research participants will fill out the survey, so that I may improve the process of informing
future research participants before they agree to participate in a clinical trial.
Completion of the survey means that you are 18 years of age or older and have given your
consent to participate in this study.
If you have any questions about this research project, or the survey, please email me at
djpalmer@uwm.edu. Thank you for your time.
Sincerely:
Debra Gillespie, RN, MS
Principle Investigator
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APPENDIX D
Demographic Information Sheet
Age: __________
Gender: Male ___

Female ___

Have you ever been a subject in clinical research before enrolling in your oncology study?
Yes ___ No ___
Approximate household income per year:
Less than $25,000 per year ___
$25,001- $50,000 ___
$50,001- $75,000 ___
$75,001- $100,000 ___
More than $100,000 ___
What is the highest level of education you have completed?
0-8 years ___
9-12 years (high school graduation) ___
High School Diploma/GED (no college) ___
1-2 years of college ___
4 years of college ___
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APPENDIX E
Quality of Informed Consent
SECTION A: Below you will find several statements about clinical trials (otherwise known as
research studies). Thinking about your clinical trial, please read each statement carefully. Then
tell us whether you agree with the statement, you disagree with the statement, or you are unsure
about the statement by circling the appropriate response. Please respond to each statement as
best you can. We are interested in your opinions.

A1.

When I signed the consent form for my current
cardiology therapy, I knew that I was agreeing to
participate in a clinical trial.

Disagree1

Unsure2

Agree3

A2.

The main reason cardiology clinical trials are
done is to improve the treatment of future
cardiology patients.

Disagree1

Unsure2

Agree3

A3.

I have been informed how long my participation
in this clinical trial is likely to last.

Disagree1

Unsure2

Agree3

A4.

All the treatments and procedures in my clinical
trial are standard for my type of cardiac disease.

Disagree1

Unsure2

Agree3

A5.

In my clinical trial, one of the researchers’ major
purposes is to compare the effects (good and bad)
of two or more different ways of treating patients
with my type of cardiac disease, in order to see
which is better.

Disagree1

Unsure2

Agree3

A6.

In my clinical trial, one of the researchers’ major
purposes is to test the safety of a new drug or
treatment.

Disagree1

Unsure2

Agree3

A7.

In my clinical trial, one of the researchers’ major
purposes is to find the highest dose of a new drug
or treatment that can be given without causing
severe side effects.

Disagree1

Unsure2

Agree3

A8.

In my clinical trial, one of the researchers’ major
purposes is to find out what effects (good and
bad) a new treatment has on me and my cardiac
disease.

Disagree1

Unsure2

Agree3

A9.

The treatment being researched in my clinical
trial has been proven to be the best treatment for
my type of cardiac disease.

Disagree1

Unsure2

Agree3
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A10.

In my clinical trial, each group of patients
receives a higher dose of the treatment than the
group before, until some patients have serious
side effects.

Disagree1

Unsure2

Agree3

A11.

After I agreed to participate in my clinical trial,
my treatment was chosen randomly (by chance)
from two or more possibilities.

Disagree1

Unsure2

Agree3

A12.

Compared with standard treatments for my type
of cardiac disease my clinical trial does not carry
any additional risks or discomforts.

Disagree1

Unsure2

Agree3

A13.

There may not be direct medical benefit to me
from my participation in this clinical trial.

Disagree1

Unsure2

Agree3

A14.

By participating in this clinical trial, I am helping
the researchers learn information that may benefit
future cardiac patients.

Disagree1

Unsure2

Agree3

A15.

Because I am participating in a clinical trial, it is
possible that the study sponsor, various
government agencies, or others who are not
directly involved in my care could review my
medical records.

Disagree1

Unsure2

Agree3

A16.

My doctors did not offer me any alternatives
besides treatment in this clinical trial.

Disagree1

Unsure2

Agree3

A17.

The consent form I signed describes who will pay
for treatment if I am injured or become ill as a
result of participation in this clinical trial.

Disagree1

Unsure2

Agree3

A18.

The consent form I signed lists the name of the
person (or persons) whom I should contact if I
have any questions or concerns about the clinical
trial.

Disagree1

Unsure2

Agree3

A19.

If I had not wanted to participate in this clinical
trial, I could have declined to sign the consent
form.

Disagree1

Unsure2

Agree3

A20.

I will have to remain in the clinical trial even if I
decide someday that I want to withdraw.

Disagree1

Unsure2

Agree3
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SECTION B: When you signed the consent form to participate in your clinical trial, how well
did you understand the following aspects of your clinical trial? If you didn’t understand the item
at all, please circle 1. If you understood it very well, please circle 5. If you understand it
somewhat, please circle a number between 1 and 5.
I Didn’t
Understand
This at All



I Understood
This Very
Well

B1.

The fact that your treatment involves research

1

2

3

4

5

B2.

What the researchers are trying to find out in
the clinical trial

1

2

3

4

5

B3.

How long you will be in the clinical trial

1

2

3

4

5

B4.

The treatments and procedures you will
undergo

1

2

3

4

5

B5.

Which of these treatments and procedures are
experimental

1

2

3

4

5

B6.

The possible risks and discomforts of
participating in the clinical trial

1

2

3

4

5

B7.

The possible benefits to you of participating in
the clinical trial

1

2

3

4

5

B8.

How your participation in this clinical trial may
benefit future patients

1

2

3

4

5

B9.

The alternatives to participation in the clinical
trial

1

2

3

4

5

B10. The effect of the clinical trial on the
confidentiality of your medical records

1

2

3

4

5

B11. Who will pay for treatment if you are injured or
become ill because of participation in this
clinical trial

1

2

3

4

5

B12. Whom you should contact if you have questions
or concerns about the clinical trial

1

2

3

4

5

B13. The fact that participation in the clinical trial is
voluntary

1

2

3

4

5

B14. Overall, how well did you understand your
clinical trial when you signed the consent form?

1

2

3

4

5
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APPENDIX F

Reminder Postcard

Date

This is a friendly reminder to complete the
Quality of Informed Consent survey that was
recently mailed to you. Place the completed
survey in the stamped returned envelope provided
to you. If you have already completed the survey,
thank you.

Figure 1. Front of Postcard

Debra Gillespie

Name
Address

Figure 2. Back of Postcard
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APPENDIX G
Teach Back Educational Presentation
Slide 1

Understanding the Basic Principles
of Teach Back

Debra Gillespie RN, MS
Doctoral Candidate
University of Wisconsin, Milwaukee
May 2016

Slide 2

Purpose
The purpose of this activity is to discuss miscommunication and its
impact on patients and to strategize methods using teach back to
improve communication

Declarations
No conflict of interest has been identified for this program.
There is no commercial support for today’s program.
In order to receive contact hours please sign the roster, complete
the evaluation, and attend the entire program.
This continuing nursing education activity was approved by the Northeast
Multi-State Division (NE-MSD), an accredited approver by the American Nurses
Credentialing Center’s Commission on Accreditation.
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Slide 3

Objectives

 List 3 patient problems caused by miscommunication
 Describe one model used to describe teach back
 Demonstrate teach back communication during role play

Slide 4
Health Literacy

“The degree to which individuals have the capacity to obtain, process,
and understand basic health information and services needed to make
appropriate health decisions”
Institute of Medicine (2004).
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Slide 5

Background
 Ninety million adult Americans have basic or below basic health literacy (reading

level 1 or 2) National Adult Literacy Survey (NALS)
 Maine has 400,000 adults (42% of the adult population) functioning at reading

Level 1 and 2

Level 1: defined as having difficulty finding information in unfamiliar or
complex texts such as newspaper articles, medicine labels, forms, charts
This is an adult who can not read well enough to fill out an
application, understand a food label, or read a story to a child. (15% of Maine's
adults function at this level)
Level 2: can identify key pieces of information and perform simple calculations
such as those on an order form (27% of Maine's adults function at this level)

Slide 6

Additionally....
 40-80% of medical information is forgotten almost immediately with the

greater the information being given proportional to the amount of
information forgotten (Kessels, R. (2003).

 Low health literacy costs the U.S. economy $106-238 billion dollars

annually (Friedland, R., 2002).

 Studies demonstrate causal relationships between poor health literacy

and poor health outcomes such as increased hospitalizations, increased
use of the ED, and increase in medication errors

 Patients are often readmitted due to adverse event related to






Lack of understanding of discharge instructions
Not sure of what danger signs to watch out for
Not sure about follow up tests and procedures
Not sure of exact medication regimen
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Slide 7

Background in Research Participants

 There is a body of knowledge demonstrating that research participants

have significant misunderstandings about the potential benefits, risks
and other aspects of their research study
 As many as 25-60% of research participants are unable to recall or

understand important information during the research consenting
process (Aaronson, et al., 1996; McCarthy et al., 2012)
 Research has also shown that patients think they understand even

when they don’t

Slide 8

What is Teach Back?
 Asking patients to repeat back in their own words what you have

explained to them

 Not a test of the patient, but of how well you explained a concept
 A chance to check for understanding and, if necessary, re-teach the

information

 It’s a way of speaking & writing that helps people to




Discover what they need
Understand what they have been told
Act appropriately on that understanding
Teach back is not about dumbing things down
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Slide 9

Examples of Plain, Non-Medical Language

Instead of this

Say this

Benign

Not cancer

Fracture

Broken bone

Inhaler

Puffer

Hypertension

High blood pressure

Oral

By mouth

Ambulate

Walk

Optimal

Best way

Slide 10

Use Language the Patient will Understand
─ Avoid Acronyms
 instead

of “HDL”, explain “good cholesterol”

─ Avoid Abbreviations and Technical Terms
 instead of “anti-hypertensive”, explain “drugs that help to lower
blood pressure”
─ Be Specific and Clear
 instead of “don’t go crazy with salt”, explain “keep your salt intake
to x mg per day”
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Slide 11

Goals of Teach Back
 Empower the patient to be able to make an informed decision
 Check for understanding and correct any misunderstandings
 Avoid rushing the patient
 Provide education when the patient is not hurried, anxious, bewildered,

passive, or distracted

 Present factual information rather than a personal interpretation

Slide 12
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Slide 13

Teach Back Demonstration

 Please click on the link below to watch a demonstration

 http://youtu.be/IKxjmpD7vfY

Slide 14

Questions to Establish Rapport

 “I’d like to be certain I have explained the risks of your clinical trial.

Can you tell me what the potential risks of this study are should you
decide to enroll?”

 “If you enroll into this study, you will be randomized to receive one of

two different treatments. Can you tell me what is meant by
randomized?”

 “Tell me what you heard me say about the benefits to you if you enroll

into this study.”
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Slide 15

Teach Back Scripts

 “I want to make sure I explained everything clearly. If you were trying

to explain about this clinical trial, what would you say?”

 “Let’s review the main risks of this study. What are some things that I

mentioned were possible risks?”

Slide 16
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APPENDIX H
Understanding the Basic Principles of Teach Back-Quiz
Please answer the following questions by circling the correct response.
1. Approximately how many Americans are said to struggle with health literacy?
A.
B.
C.
D.

200,000
1 million
90 million
42 million

2. Patients with limited health literacy are more likely to be re-admitted to the hospital
due in part to which of the following?
A.
B.
C.
D.

Not understanding how and when to take their medications
Not clear on when they may have follow up appointments and tests
Not understanding their hospital discharge instructions
All of the above

3. According to research, approximately how many research participants do not
understand their clinical trial?
A.
B.
C.
D.

Up to 10 percent
Between 25-60 percent
Between 70-80 percent
Between 80-90 percent

4. Some key concepts to discuss when consenting a patient for a clinical trial include
(circle all that apply)
A.
B.
C.
D.

The investigator’s name and phone number
The potential risks to the subject
The voluntary nature of research participation
How research is no different than their standard care
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5. Techniques to improve health literacy include (circle all that apply)
A.
B.
C.
D.

The patient repeats back to you in their own words what you have told them
If a patient nods “yes” in agreement, this indicates they understand you
Using plain language instead of medical jargon
Using simple yes/no questions to avoid confusing the patient

6. Communication theory may support clinicians to practice the use of teach back.
What specific communication model guides this practice?
A.
B.
C.
D.

The Baxter Method of Communication
The Berlo Communication Theory
The Sherman Communication Theory
The Shannon-Weaver Communication Theory

7. Patients who are only able to read at reading level 1 would have difficulties reading
the following:
A.
B.
C.
D.
E.

A newspaper
A children’s book
A job application
A and C only
All of the above

8. Studies have shown a causal relationship with poor health literacy and which of the
following (circle all that apply)
A.
B.
C.
D.

An increase in hospitalizations
An increase in falls among the elderly
An increase in trips to the Primary Care Physicians
An increase in medication errors

9. Some examples of replacing medical jargon with plain language would include
(circle all that apply)
A.
B.
C.
D.

Saying “hypertension” rather than “high blood pressure”
Saying “broken bone” rather than “fracture”
Saying “not cancer” rather than “benign”
Saying “ambulate” rather than “walk”
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10. Teach back is (circle all that apply)
A.
B.
C.
D.

A way to capture the patient’s attention
A way to check for patient understanding
A method used to dumb down information to patients
A measure of how well you have explained something to the patient
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